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 Abstract: 
 
Most of the cancer cells and primary cancers show increased expression of various 
membrane proteins including ion channels, receptors like EGFR, integrin receptors etc. In this work 
we characterized the expression of potassium ion channels Kv11.1 (hERG1), EGFR and integrins in 
pancreatic ductal adenocarcinoma (PDAC). Firstly, our study shows that hERG1 specific blocking 
decreases the PDAC cell proliferation and anchorage independent colony formation. The study 
further demonstrates that blocking of hERG1 channels modulates the MAPK signaling pathway 
most likely mediated by EGFR receptors. In deed hERG1 makes complex formation with EGFR in 
both PDAC cell lines and primary samples. We then investigated the interactions between hERG1 
and integrins. HERG1 and β1 integrins complex formation requires both functional hERG1 
channels and activated β1 integrins. In other words, functional blocking of hERG1channels or non-
stimulated β1 integrin or both would impair the complex formation between hERG1 and β1. We 
further demonstrate, using model cell lines, that the interactions between hERG1 and β1 could 
occur through transmembrane domains.  
 
We further investigated the role of hERG1 channels in PDAC cell adhesion, migration and 
actin cytoskeleton organization. HERG1 specific blocking did not affect the integrin-mediated cell 
adhesion and focal adhesion formation on ECM proteins. However, when hERG1 was blocked we 
observed the alterations in filamentous actin organization mediated by β1 integrins. HERG1 
blocking specifically induced longer and finely organized f-actin in the cytoplasm, whereas over 
expression of hERG1 channels induced scattered shorter filaments. Next, we studied the role of 
hERG1 channels in cell migration and actin dynamics. For this purpose we challenged the role of 
hERG1 channels in multifactorial dynamic system that is similar to tumor microenvironment. 
PDAC cells were stimulated with conditioned media of hypoxia activated pancreatic stellate cells 
and, migration and actin dynamics were quantified. HERG1 blocking decreased the migration rate 
and interestingly, increased the actin flow (velocity). The increase in velocity was found to be due 
to increase in diffusion co-efficient of actin flow. Finally, we hypothesize that the hERG1 could 
mediate the actin dynamics and migration by altering the intracellular calcium concentration 
([Ca2+]i). In fact hERG1 blocking decreased the [Ca2+]i by more than two-fold. 
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1. INTRODUCTION 
1.1. Pancreatic Cancer and causes of pancreatic cancer 
Cancer, defined in the simplest form, is a disease stemmed from uncontrolled 
growth of cells. The history of cancer dates back to thousands of years. Greek 
physician Hippocrates, between 470-360 BC, coined the terms carcinos and 
carcinoma to describe non-ulcer and ulcer forming tumors. However, the 
documentation of cancer disease in humans and animals dates back further to around 
3000 BC. Cancer (interchanged with the word tumor) is caused from wide array of 
factors like exposure to cancer causing agents (carcinogens), chronic infections (from 
for ex, hepatitis viruses, papilloma virus), life styles (eating, drinking, smoking 
habits, physical activities) and inherited genetic susceptibility to environment factors 
etc. (Ames and Gold, 1998).  
From genetics point-of-view cancer is caused by accumulation of series of 
mutations either in oncogenes (tumor promoting) or tumor suppressor genes in 
normal cells over several years. This leads to severe alterations in both phenotypic as 
well as genotypic characteristics of transformed cells. During this transformation 
cells typically have to acquire certain set of capabilities that are ‘hallmarks of cancer’ 
to cause neoplastic disease. The seminal review paper by Hanahan and Weinberg 
categorizes the capabilities of diverse complex cancer tissue into six groups; 
sustaining proliferative signaling, evading growth suppressors, resisting cell death, 
enabling replicative immortality, inducing angiogenesis, and, activating invasion and 
metastasis (Hanahan and Weinberg, 2011). 
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Scheme-1. Six hallmarks of cancer that is essential for the transformed cells to cause 
neoplastic disease (adapted from Hanahan and Weinberg. 2011). 
 
1.1.1. Pancreatic ductal adenocarcinoma (PDAC) and 
characteristics/progression of PDAC 
Tumors arising from the epithelium of exocrine pancreas are the most 
common type of pancreatic cancer that amount for over 95% of the pancreatic cancer. 
In this pancreatic adenocarcinoma (PDAC) is the most common type of exocrine 
pancreatic cancer that amount for more than 90% of the pancreatic cancer. Hence 
most of the time pancreatic cancer is generally referred to PDAC. PDAC is perhaps 
the most lethal form of cancer with five-year survival rate at dismal less than 5% and 
medial survival period is 6 months. PDAC arises from the ductal region of the 
pancreas and hence the term PDAC. Like any cancer the risk of acquiring PDAC is a 
multifactorial phenomenon; such as advanced age (>65), smoking (Fuchs et al., 
1996), sex (male has 30% higher risk than female) and long standing chronic 
pancreatitis (Guerra et al., 2007) are the major risk factors followed obesity, diabetes 
and family history of PDAC patients (Hezel et al., 2006). These factors contribute to 
the series of accumulative genetic alterations such as point mutations, up regulation 
or down regulations of some key genes in normal ductal epithelial cells that 
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subsequently lead to transformed malignant cells as depicted in scheme-2. Studies 
show that this clonal evolution from non-invasive to invasive metastasized cells 
process takes around 10 years (Campbell et al., 2010; Yachida et al., 2010). This 
provides a window of opportunity for early detection and mapping of genetic changes 
that take place in transforming the ductal cells before they become invasive. Studies 
like whole genome sequencing and copy number variation (CNV) on PDAC patients 
have been performed to identify the key mutations in oncogenes, association of 
genomic instability with inactivation of DNA maintenance genes and mutational 
signatures in DNA damage repair deficiency (Waddell et al., 2015). There are, on 
average, as many as 63 gene alterations in PDAC but the four most commonly 
observed mutations include oncogene KRAS, and three tumor suppressor genes 
CDKN2A, TP53 and SMAD 54. PDAC patients possessing mutations in all four 
genes have lower survival rate compared to 1 or 2 mutations (Yachida et al., 2012). 
Studies reveal that twelve core signaling pathways including apoptosis, DNA damage 
control, KRAS, integrin signaling, adhesions etc are altered in more than two third of 
the cancer (Jones et al., 2008).        
Scheme-2. Progression from normal pancreas to metastatic pancreatic cancer adapted from 
(Iacobuzio-Donahue et al., 2012).   
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1.1.1.1. Precursor lesions as indicators of future invasive PDAC 
Pancreatic intraepithelial neoplasias (PanIN) are histologically distinct well-
defined precursor lesions to invasive ductal adenocarcinoma that was first observed 
40 years ago (Cubilla and Fitzgerald, 1976). PanIN lesions are characterized to be 
small and difficult to detect clinically and are commonly observed in elderly 
population. Genetic analyses of PanIN lesions demonstrate that almost 100% of even 
the lowest grade PanIN (PanIN-1) harbors some of the most prominent genetic 
alterations that are sustained till the cells become invasive (Kanda et al., 2012). For 
example telomere shortening and mutations in KRAS are among the earliest genetic 
alterations that occur since PanIN-1 (van Heek et al., 2002). These mutations are 
followed by mutations in tumor suppressors CDKN2A in mid-stage-PanIN-2 and, 
TP53 and SMAD4 in later stage-PanIN-3 (Iacobuzio-Donahue, 2012). This group of 
mutations, along with other, albeit less frequently occurring, mutations like BRCA1, 
MLL3 etc. may be considered to be initiating mutations that could drive the 
malignancy of cells. Hence the early detection of these genetic alterations and their 
downstream effects could represent an opportunity for probable cure of preinvasive 
neoplasia.  
Intraductal Papillary Mucinous Neoplasms (IPMNs) are also precursor lesions 
to invasive PDAC and present a similar opportunity like PanIN towards early 
detection and curable neoplasia. IPMNs are large enough lesions that can be detected 
clinically and serves as an indication of pancreatic cancer. Studies show that >95% of 
IPMNs, particularly pancreatic cysts (fluid filled neoplasms in the pancreas) have 
shown to possess genetic mutations, for ex in KRAS and GNAS, that are associated 
with invasive PDAC (Wu et al., 2011). These evidences reinforce that IPMNs are 
bona fide precursor lesions progressing towards PDAC. 
1.1.1.2. Metastasis of PDAC 
When the non-invasive cells transform into malignant invasive cells they 
overgrow and eventually disseminate from primary site to distant organs causing 
secondary tumours called as metastasis. Most of the PDAC patients, at the time of 
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diagnosis, have metastatic stage and most often cancer related deaths are due to 
metastasis. As mentioned above, from an initiated pancreatic tumor cell, for ex in 
PanIN-1 stage, to disseminate and induce metastasis it takes longer than 10 years as 
estimated by mathematical model by Yachida et al (Yachida et al., 2010). 
Interestingly, in spite of such a long relatively slower progression of cancer, most of 
the genetic changes from the primary cancer were retained in metastases cancer. 
Another study involving larger group of patients show that 70% of the patients’ death 
suffered from metastasis and 30% of deaths had locally destructive pancreatic cancer. 
The autopsy analyses indicate that only metastasis was closely correlated to the loss 
of tumor suppressor gene SMAD4 (Iacobuzio-Donahue et al., 2009). Another set of 
computational modelling of as large as 200 patients’ samples (resected and autopsied 
combined) predicts that tumor growth of pancreatic cancer would exponential at the 
time of diagnosis prompting both early as well as timely diagnosis and treatment are 
quintessential for effective treatments (Haeno et al., 2012). However, larger role in 
tumor progression is played by the microenvironment of the tumor cells that include 
stromal cells, immune cells and their secreted proteins etc.  
1.1.2. PDAC tumor microenvironment (TME) 
PDAC is characterized to be highly dense and poorly vascularized stroma due 
to desmoplastic reaction. This PDAC stroma, collectively called as tumor 
microenvironment (TME), has a complex cellular compartment including tumor cells, 
immune cells, fibroblasts, inflammatory cells, endothelial cells etc. These individual 
cellular compartments interact with each other by secreting proteins like extracellular 
matrix (ECM), growth factors (GFs), cytokines, interleukins etc. and contribute to the 
overall progression of the tumor. A schematic representation of TME is shown below 
in scheme-3. Within the vastly heterogenic TME we limit our focus to pancreatic 
stellate cells (PSCs), key secretomes of PSCs and, ion channels and integrins. 
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Scheme-3. Schematic representation of TME and its key components adapted from(Arcangeli, 
2011).  
1.1.2.1. Stromal fibroblasts-Pancreatic stellate cells (PSCs) 
Pancreatic stellate cells (PSCs) form one of the major components of TME. 
PSCs in healthy tissues exist in inactive quiescent state with large lipid storage rich in 
vitamin A as a characteristic feature. However, under chronic or acute pancreatitis 
(inflammation) PSCs are activated where they loose lipid storage and instead express 
alpha-smooth muscle actin (α-sma). Inflammation in pancreas like chronic 
pancreatitis is considered to be a major risk factor in developing PDAC and 
independent of sex, country and type of pancreatitis (Lowenfels et al., 1993). 
Activated PSCs show increased cell proliferation, migration to the wounded region 
and deposition of ECM proteins (fibrosis). In addition, activated PSCs secrete as 
many as 641 proteins while quiescent PSCs secrete a meagre 46 proteins. More than 
35% of these secreted proteins were implicated, according to KEGG database, in 
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cellular processes, signaling pathways or human diseases (Wehr et al., 2011). PSCs 
and PDAC cells interact in a paracrine fashion that is, through secretion of signaling 
molecules that induce the changes in one another. Increasing evidence suggests that 
these activated PSCs, through secretion of various proteins, activate the PDAC cells 
and promote tumor progression. Notably, the secretion of ECM proteins like 
collagen-1, fibronectin and cytokines provide chemoresistance, GFs like PDGF, EGF, 
TGFβ induce cell proliferation and migration, proteases like matrix metallo proteases 
(MMPs) in invasion of PDAC cells (Tang et al., 2013). The cross talks between PSC 
and PDAC are studied in monolayer or three-dimensional co-culture systems. The co-
culturing has shown to increase the PDAC cell proliferation by the secretion of GFs 
and cytokines from PSCs. Interestingly, in co-culture as well as in mice, when 
quiescence of PSCs were induced by all-trans retinoic acid (ATRA) the proliferation 
of PDAC cells decreased, increased cell apoptosis and altered tumor morphology 
indicating that activated PSCs is essential for PDAC cell proliferation (Froeling et al., 
2011). In vivo experiments also corroborate similar observations where co-injections 
of PDAC and PSC cells increase the tumor progression rate and metastasis (Hwang et 
al., 2008; Vonlaufen et al., 2008). The interaction between PDAC and PSCs are 
mutual beneficial in which they stimulate each other’s growth and migration through 
the secreted proteins and thrive together. The conditioned media of activated PSCs 
when added to PDAC cells have shown to increase cell proliferation, migration and 
invasive capabilities and altered phenotype of PDAC cells (Lu et al., 2014). 
Similarly, the conditioned media of PDAC cells can further stimulate PSCs 
proliferation, activation, secretion of collagen-1 etc. (Apte et al., 2004). Hence it is 
increasingly perceived that activated PSCs can be a potential target to suppress the 
tumor protection and progression. Some of the key secreted proteins and their roles in 
TME are explained below. 
1.1.2.2. Secreted proteins in TME 
1.1.2.2.1. Extra cellular matrix (ECMs) 
PDAC is characterized to be highly desmoplastic with large amounts of ECM 
proteins deposited around the tumor cells. PSCs are the chief source of ECM 
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consisting of collagen-1 (more than 90%), fibronectin, proteoglycans, hyaluronic acid 
and other ECMs. The constant accumulation of these ECMs distorts the normal 
architecture of the pancreas tissue and induces abnormal blood and lymphatic vessels 
as well as brings the ECMs and PSCs closer to cancer cells (Gnoni et al., 2013; 
Armstrong et al., 2004). In addition, ECM deposition around the tumor cells protects 
them against any therapeutic drugs and, also confines the tumor cells within the 
microenvironment. However, ECM turnover (synthesis, secretion and degradation) is 
critical in tissue remodeling in both normal as well as pathological processes. PSCs, 
when exposed to proinflammatory proteins like TGF-B, IL-6, secrete enzyme class 
matrix metalloproteinases (MMPs) that degrade ECM (Phillips et al., 2003). Cancer 
cells exploit this well-coordinated ECM turnover to migrate closer to blood vessels 
and further induce angiogenesis for eventual dissemination to distant organs. 
1.1.2.2.2. Other proteins 
TME is highly heterogenic and dynamic with rich source of proteins secreted 
by various types of cells. These proteins include GFs, cytokines, interleukins, 
proteases etc. specifically secreted by both PSC and PDAC cells. PDAC is also 
characterized to be hypoxic due to over growth of cancer cells. The GFs include 
EGF, VEGF, PDGF, IGF, TGF-B, FGF (fibroblast GF) that regulate wide range of 
signaling cascades in both normal as well as pathological process as reviewed in 
(Nandy and Mukhopadhyay, 2011). 
- Epidermal growth factor (EGF):  
EGF is a ligand that binds to EGF-receptors. EGFRs are one of the key 
receptors that are consistently up regulated in many tumors including PDAC. The 
EGF binding to EGFR leads to autophosphorylation of EGFR that in turn initiate cell 
proliferation signaling and thus excessive presence of EGF leads to increased 
proliferation. The EGF molecules are secreted by both PDAC and PSC cells and are 
involved in autocrine as well as paracrine function. 
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- Vascular endothelial growth factor (VEGF): 
Both normal and pathogenic pancreas development involve angiogenesis- the 
process of new blood vessel formation. Many GFs like VEGF, PDGF, TGF-β, bFGF 
etc. are involved in angiogenesis, but VEGF is the most potent angiogenic factor that 
binds to VEGF-R and involved in every step of angiogenesis. Rapidly growing tumor 
cells need constant supply of nutrients through blood vessels. But because of the over 
growth of tumor and excess fibrosis the tumor cells are deprived of nutrients that are 
essential to support their growth rate. Hence these tumor cells secrete VEGFs that 
increase blood vessel formation and nutrient supply. 
- Platelet derived growth factor (PDGF):  
There are four PDGFs; PDGF-A, B, C and D that bind to either homo or 
heterodimer PDGF-receptors and modulate cell proliferation and migration signaling 
pathways detailed in review (Heldin, 2013). The PDGF and its receptors have 
important functions in regulation of growth and tissue repair; however, over 
expression and mutational activity of the PDGF-Rs drive the excessive cell growth 
and migration of both malignant and non-malignant cells. At the initial stage of 
pancreatitis macrophages and ductal cells are the main source of PDGFs that cause 
activation of fibroblast and proliferation. Over expression of PDGF-D has shown to 
increase the migration and invasion of PDAC cells and positively regulate activation 
of matrix metalloprotienase-9 (MMP-9) and VEGF (Wang et al., 2008). 
- Matrix metalloprotienases (MMPs):  
MMPs are calcium dependent zinc containing enzyme proteins that are 
capable of degrading ECMs. As mentioned above PDAC is characterized to be 
highly desmoplastic with excess accumulation of ECMs mainly collagen-1. Even 
though PDAC cells have shown to secrete MMPs it is PSCs that are the major source 
of MMPs that are involved in remodeling of fibrosis and ECM turnover 
(Schneiderhan et al., 2007). It is a necessary step for cells to degrade the ECMs in 
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order for the PDAC cells to migrate and invade to distant organs and, treating of 
MMP inhibitor has shown to reduce the invading cells (Ellenrieder et al., 2000).   
- Cytokines:  
Cytokines are another class of small molecule proteins that are secreted at 
higher levels in PDAC TME. Several types of cells within TME secrete both pro and 
anti-inflammatory cytokines that are involved in proliferation, migration, 
angiogenesis, EMT, poor prognosis etc. as summarized in review (Roshani et al., 
2014). Clinical study of comparison between healthy and pancreatic cancer patients 
suggest that elevated expression of cytokines like interleukin-1 receptor antagonist 
(IL-1RA), IL-6 and IL10 expression had worse overall survival rate (Ebrahimi et al., 
2005). 
1.1.3. Immune/inflammatory cells 
The TME has shown to be infiltrated by various inflammatory immune cells 
as an act of immune surveillance. This include cells of adaptive immunity like T 
lymphocytes, dendritic cells and occasionally B cells as well as cells of innate 
immunity like macrophages, natural killer (NK) cells etc. (Whiteside, 2008). The size 
of the infiltration of these cells could vary from tumor-to-tumor. Despite the 
recruitment of these immune cells as a defence mechanism against tumor cells, the 
tumor continues to grow: it could be because the adaptive immunity is weak and 
largely inefficient (Arcangeli, 2011). In addition, the cellular and molecular events in 
TME are often orchestrated and dominated by tumor cells in which tumor cells cause 
dysfunction and death of immune cells or worst cases immune cells are involved in 
promoting growth of tumor cells(Whiteside, 2008; Arcangeli, 2011). For example, 
tumor-infiltrating lymphocytes (TIL) obtained from tissue samples, the major 
component of immune infiltrates in tumor, showed inhibited proliferation in response 
to antigens, compromised signaling through T-cell receptor (TCR) and inability to 
induce cytotoxicity towards tumor cells. It is also shown that except for effector T 
cells, immunosuppressive cells like tumor-associated macrophages, myeloid derived 
suppressor cells (MDSC) and T regulatory cells (Treg) except effector T cells are 
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recruited to the tumor site at the early stage and persist till the invasive cancer but 
tumor still grows. This suggests that effective immune defensive mechanism against 
tumor is undermined from the start (Clark et al., 2007). Recently, a comprehensive 
study identifies some of the key immune cells that, when recruited to TME in higher 
levels, are either associated with shorter or longer survival of PDAC patients (Ino et 
al., 2013). 
1.1.4. Ion channels and integrins in TME 
The TME, due to shift of cellular metabolism to towards excessive 
glycoslysis, is characterized to be physiologically acidic and, also spatio-temporally 
dynamic as tumor growth continues (Dang, 2012). The secretome of the TME are 
involved in stimulating various receptor proteins as well as strategically placed other 
membrane proteins like ion transporters and channels of cells. Both ion channels and 
integrin receptors are ubiquitously expressed in all cells with varying degree that 
play key role in regulating normal as well as pathophysiology of cells that are 
explained in separate sections below. Integrins are adhesion molecules used by cells 
to anchor to its environment like ECMs (cell-matrix) or other cells (cell-cell 
interactions) and are involved in modulating broad cell signaling including adhesion, 
migration, and angiogenesis. Ion channels and transporters (ICTs) are also activated 
in the acidic TME where protons are exchanged between intracellular and 
extracellular space notably through sodium proton exchangers (NHE) (Andersen et 
al., 2014). It has been shown that ion channels and integrins (β1) interact and 
modulate each other’s function. One such example is activation of integrins through 
ECMs increased the ion conductance of potassium ion channels HERG1 (also called 
as hERG1) while functional blocking of channels interrupted integrin mediated 
signal (Cherubini et al., 2005). Also HERG1 channels make molecular complexes 
with EGFRs and other heterodimer integrins in PDAC cells that are involved tumor 
growth and angiogenesis. In the following sections below the detailed role of ion 
channels and integrins in cancer cell behaviour are mentioned.  
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1.2. Role of potassium ion channels in cellular physiology of 
cancer cells and cancer progression 
The development of noble prize-winning patch clamp method by Bert 
Sakmann and Erwin Neher led to tremendous breakthrough in ion channel research. 
Ion channels are the integral membrane proteins that regulate ion flow and thus 
voltage gradient across the membrane. The presence of ion channels and transporters 
at the plasma membrane allow the ions like Na+, K+, Ca2+, Cl- to pass across the 
membrane through specific ion channels. All cellular physiological processes depend 
on the flow of ions across the membrane barrier and this lead to the large electric 
potential difference between two sides of the membrane. The difference further leads 
to the switching of ion channels between conductance (open) and non-conductance 
(closed) state to restore the homeostasis of the membrane potential. The ion transport 
across the membrane barrier is characterized as ‘passive’ (i.e. without the need of 
energy) ion conductance driven by membrane potential (Vm). These ion channels 
play critical role in cellular physiology including cell volume, cell shape, cell cycle 
progression, cell proliferation, signaling, and apoptosis (programmed cell death)  
(Jehle et al., 2011) and thus any abnormalities in ion channel functioning will lead to 
pathophysiology (Kaczorowski et al., 2008). The list of pathophysiological diseases 
associated with ion channels has been discussed in the review articles (Jentsch et al., 
2004; Hübner and Jentsch, 2002).  
Over the last 15-20 years scientists have shown that ion channels are 
aberrantly expressed in many human cancers and they are involved in promoting 
hallmarks of cancer like continuous cell cycle progression, proliferation and 
migration. More importantly, because of the high expression of these ion channels at 
the early stage of tumor formation, they are considered to be effective biomarkers for 
early detection of cancer and perhaps as potential drug target for treatment of cancer. 
In the subsequent sections below, expression of ion channels in many human cancer 
tissues and cells and their functional of role in tumor cell progression, proliferation, 
migration as well as potential drug target are explained. 
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1.2.1. Ion channels as biomarkers and prognostic markers in cancer 
1.2.1.1. Ion channels as biomarkers in cancer diagnosis, prognosis and 
potential drug targets.  
Although ion channels are one of the most indispensable membrane molecules 
for normal physiological processes of cells, some specific ion channels are explicitly 
implicated only under pathological conditions like cardiovascular disorders, 
neurological disorders, cancers etc. The group of pathological conditions are referred 
as ‘channelopathies’ (channels in pathology). The diseases are directly linked to stem 
from the dysfunction of ion channels due to mutations, altered membrane trafficking 
etc. (Dworakowska and Dołowy, 2000). The scheme-4 below shows the differential 
expression of various ion channels in healthy and cancer cells and the implication of 
ion channels in promoting hallmarks of cancer. Cancer cells express vast number of 
ion channels that are typically absent in healthy cells. 
 
 
Scheme-4. The differential expression of ion channels in healthy and tumor cell and their involvement 
in hallmarks of cancer (Lastraioli et al., 2015).  
Over the last 30 years scientists have shown mounting evidence about the 
functional role of ion channels in life threatening diseases particularly in cancer and 
is consistently proven that ion channels are involved in regulating the hallmarks of 
cancer (Hanahan and Weinberg, 2011; Prevarskaya et al., 2010). Among many types 
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of ion channels such as voltage gate sodium channels (VGSCs), chloride (Cl-) 
channels, calcium activated potassium channels (KCa) etc. are involved in cancer, 
voltage gated potassium ion channels (Kv) are the most abundant ion channels coded 
by more than 70 human genes identified until now that are involved in cancer 
progression (http://www.guidetopharmacology.org/GRAC/IonChannelListForward?class=VGIC). 
The scheme-5 below shows the involvement of various K+ channels in many 
hallmarks of cancer. As can been observed any ion channel can be involved in more 
than one hallmarks of cancer suggesting its importance in multistep process of cancer 
progression starting from hyperproliferation to invasion and metastasis. The detailed 
list of expression of vast number of ion channels in various cancer cells and tissues 
has been extensively reviewed in (Arcangeli et al., 2009; Bose et al., 2015). 
 
Scheme-5. Potassium ion channels and their role in hallmarks of cancer (Prevarskaya et al., 2010) 
Because of the involvement of these ion channels in multistep process of 
tumor progression they have been identified as prognostic markers in overall survival 
of many cancer patients. For instance, in breast cancer, large scale high-throughput 
expression profiling of 280 genes coding for ion channels that are in association with 
p53 mutation, estrogen receptor (ER) status and histological tumor grade predicts the 
overall clinical outcome (Ko et al., 2013). The ether-a-go-go (EAG) family of Kv10.1 
ion channels have also been identified in several cancer cells, which are otherwise 
expressed only in brain tissue, and have been associated with poor prognosis. 
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Interestingly, over expression Kv10.1 was alone sufficient to increase cell 
proliferation and tumor progression in mouse models (Pardo et al., 1999). However, 
the pattern and expression level of ion channels in cancer is not always directly 
proportional, in all cancers, to its potential malignancy or overall survival rate. 
Because for ex, EAG related gene (ERG) family HERG1 was shown to be over 
expressed, including many tumor cells and tissues, in PDAC, acute myeloid leukemia 
(AML) and ovarian cancer cells and tissues. HERG1 expression level was in direct 
correlation to poor prognosis in both PDAC (Lastraioli et al., 2015; Pillozzi et al., 
2007) and AML (Pillozzi et al., 2007), but in ovarian cancer there was no correlation 
with overall survival (Asher et al., 2010). In fact some ion channels have also shown 
to be down regulated in some highly malignant tumor like high-grade glioma where 
16 out of 18 ion channels studied were down regulated (Wang et al., 2015). Similarly, 
low or dysfunctional expression of Kv7.1 and Kv1.1 is associated with hyper-
proliferative, increased aggressiveness and low survival in patients with colorectal 
(Than et al., 2014) and breast cancer (Lallet-Daher et al., 2013) respectively 
indicating both these channels could act as a tumor suppressor. Hence it is 
consistently observed that there is differential expression of various ion channels 
across several tumor cells and tissues. Since last 30 years the role of ion channels in 
cancer cell cycle progression, proliferation, migration and invasion have been 
characterized across broad spectrum of cancer. 
1.2.1.2. Role of ion channels-mediated membrane potential in cell volume 
regulation, cell cycle progression/proliferation/migration 
1.2.1.2.1. Ion channels in cell cycle progression 
The normal cell division process is divided into several phases; cell division 
starts with Gap (G1) phase, which separates previous cell division and DNA 
synthesis (S-phase) followed by second gap G2 phase and mitotic M phase. Further 
the cell can either proceed to next G1 phase for next cell division or G0 phase to 
attain quiescent state. After each phase cell has to undergo a checkpoint surveillance 
process to make sure the successful completion of previous phase. Hence these 
checkpoints are constitutive feedback pathways in safeguarding the key cell cycle 
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progression, which is however recognized to be defective in cancer cells (Urrego et 
al., 2014). 
The membrane potential (Vm), largely modulated by K+ ion channels, has 
been reported to be a key regulator of cell cycle progression. One of the well-
established biophysical properties of cancer cells is they are more depolarized than 
their normal counterparts that favours increased cell proliferation and migration 
(Binggeli and Cameron, 1980; Blackiston et al., 2009; Yang and Brackenbury, 2013). 
This could also due to the differential expression of ion channels depending on cell 
cycle. Studies on various cancerous cells and tissues like breast cancer cells, 
hepatocytes, fibroblasts, ovarian and skin cancer tissues etc. shown to have 
depolarized membrane potential (Vm) while non-proliferating or terminally 
differentiated somatic cells show hyperpolarized Vm, indicating that Vm is 
functionally suggestive in cell development (Yang and Brackenbury, 2013). These 
depolarized cells had higher intracellular Na+ concentrations than normal cells but 
K+ concentrations were stable. However, this altered Vm is just an epiphenomenon of 
the transformation of normal cell to malignant.  
The alternation in the Vm is imperative during the progression of cell cycle 
where Vm is hyperpolarized in G1/S phase through to G2 phase due to efflux of K+. 
Before cells enter M phase Vm is depolarized because of efflux of Cl- and quiescent 
cells at G0 show mitotic activity when cells are depolarized (Cone and Cone, 1976). 
It is demonstrated that depolarization of cells initiate mitosis and DNA synthesis in 
both tumor and non-tumor cells. The number of studies has shown that by 
manipulating the Vm externally cell cycle progression could be altered. For ex, by 
hyperpolarizing the Vm, using extracellular ionic solution, of CHO cells at -45mV 
mitotic arrest were induced and further at -75mV the cell division was blocked. By 
depolarizing back at -10mV the cell cycle was restored (Yang and Brackenbury, 
2013). Although the fluctuation in the Vm throughout the cell cycle progression 
heavily depends on cell type, state of differentiation and density of cell monolayer in 
culture, it is consistently observed that the mean Vm of cancer cells is depolarized 
relative to non-transformed cells and could serves as a hallmark of cancer. Voltage 
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gated K+ ion channels (Kv) are the prominent ion channels that contribute to the 
overall Vm of the cell and thus an important regulator of cell cycle progression and 
proliferation.  
1.2.1.2.2. Ion channels in cell proliferation 
Cancer cells have a characteristic feature of having sustained cell proliferation 
signaling unlike non-cancer cells. Numerous K+ channels are aberrantly expressed in 
cancer tissues and cells most often with enhanced activity. These K+ channels could 
be activated by hyperpolarization of Vm, drug induced (Lansu and Gentile, 2013), 
membrane lipids like phosphatidylinositol 4, 5 bisphosphate (PIP2), 
phosphatidylserine (PS) (Hansen, 2015; Zhou et al., 2015), integrin receptors (Levite 
et al., 2000; Cherubini et al., 2005) etc. A variety of ion channels have been linked to 
regulation of cell proliferation and pharmacological or genetic blocking of such ion 
channels has demonstrated to impede cell proliferation and in some cases even induce 
apoptosis.  
Voltage gate potassium (Kv) ion channels are the most abundant as well as 
extensively studied ion channels that are implicated in cell proliferation and 
tumorigenesis. Most of these studies showed that blocking of Kv channels resulted in 
non-conductance of ions that lead to gradient in K+ ion concentrations. Because of 
the K+ gradient the influx of Ca2+ is inhibited which is crucial to trigger cell 
proliferation and maintenance of hyperpolarized Vm (Lang et al., 2005; 2007). 
However, cell cycle progression and proliferation is solely not determined by Ca2+ 
concentrations, because experimental observations show blockers or siRNA 
knockdown of specific type of Kv channels have shown to reduce the proliferation 
and arrested the cell cycle progression. For instance, Kv10.1 was blocked by specific 
single chain antibody fused to TNF-related apoptosis-inducing ligand (TRAIL). Only 
Kv10.1 expressing prostate cancer cells were targeted and induced apoptosis 
(Hartung et al., 2011). Another channels specific antibody as well as small molecule 
drug E4031 specific for HERG1 has shown to decrease the proliferation of pancreatic 
cancer cell line (Lastraioli et al., 2015). In E4031 specific blocking of HERG1 in K-
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Ras mutated Panc1 cells led to ~50% reduction in mitogen-activated protein kinase 
(MAPK) signaling (Lastraioli et al., 2015). The simulated depolarization of Vm has 
also been shown to increase the nanoclustering of K-Ras at the membrane level and 
induce nanoscale reorganization of membrane lipids (Zhou et al., 2015). Interestingly 
Kv channels mutants for ion conductance, that is independent of ion permeation, have 
also shown to retain the influence of proliferation. It is plausible, under such scenario, 
that the impairment of ion conductance of specific channels could be compensated by 
expression of other channels. Hence the exact mechanism by which K+ channels 
modulate cell proliferation is poorly understood. There are four proposed mechanism 
by which they could alter the proliferation and cell cycle progression. They are either 
by (i) setting up membrane potential, (ii) controlling cell volume dynamics, (iii) 
regulating calcium signaling or (iv) promoting malignant growth through non-
canonical function, independent of ion permeation, where channel blocking could 
interfere with cell proliferation signaling cascade (Huang and Jan, 2014). 
1.2.1.2.3. Ion channels in cell Migration 
Most tumor cells, if not all of them, have a characteristic feature of invasion 
and metastatic in tumor progression; in which cell detach from primary tumor site 
and migrate to new position and form new attachment. The migrating cells exhibit a 
polarized feature where cell front and rear has differential polarity that is tightly 
governed, among many factors, by flow of ions and water molecules that also 
regulate cell volume, Vm and intra-and extra cellular pH. Likewise in cell cycle 
progression and proliferation intracellular concentration of Ca2+ plays a vital role in 
cell migration as well, perhaps through different mechanisms. Migration is a 
multifactorial phenomenon where cells make use of activated integrin receptors to 
move and most of the integrin function is calcium dependent. On the other hand ion 
channels mediated Vm determines the influx and efflux of Ca2+ and hence Vm could 
indirectly influence the cell migration. The intracellular calcium concentration 
([Ca2+]i) has a great impact on cell migration because the migration machineries like 
focal adhesion kinase (FAK) (Giannone et al., 2002), myosin II (Betapudi et al., 
2010), myosin light chain kinase (Tsai and Meyer, 2012), calpain, ion channels 
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(Schwab and Stock, 2014) etc. are calcium sensitive. The hyperpolarization of cells 
increases the intracellular concentration ([Ca2+]i) via transient receptor potential 
(TRP) channels or activates the voltage-gated Ca2+ channels to maintain 
depolarization (Schwab et al., 2012). Within the compartments of migrating cell, the 
[Ca2+] gradient is spatially and temporally regulated in which cell front has lowest 
[Ca2+] and cell rear has highest [Ca2+] (Brundage et al., 1991). The oscillations in 
[Ca2+] is observed within microdomains of the cell where [Ca2+] flickering occurs at 
highest level (flickering rate 4:1 front-to-rear) in lamellipodia at the cell front that 
could regulate the directionality of the migration (Wei et al., 2009). At the rear end of 
the cell Ca2+ contributes to the myosin-II dependent retraction force and dissembling 
of focal adhesion, and cytoskeleton reorganization (Brundage et al., 1991; Yang and 
Brackenbury, 2013).  
As mentioned earlier migration is a multistep phenomenon that could be 
stimulated by Vm, GFs, integrin activation and other signaling molecules. For ex 
depolarized Vm of epithelial kidney cells induces diphosphorylation of myosin light 
chain without altering the [Ca2+] but instead by activating on Rho-Rho (ROK) kinase 
pathway (Szászi et al., 2005). Ion channels are also involved in crosstalk with integrin 
receptors and modulate integrin activation and signaling. For instance, depolarizing 
the T cells by increasing external [K+] increased the β1 integrin activation which led 
to increased cell adhesion and migration (Levite et al., 2000), while blocking of 
Kv1.3 channels reduced proximity between Kv1.3 and β1 integrins in malignant 
melanoma cells (Artym and Petty, 2002). A similar observations were made with 
HERG1 channels where both HERG1 and β1 integrin reciprocally activate each 
other. On one hand functional blocking of HERG1 channel decreased the integrin-
mediated activation of FAK while on the other hand integrin activation by fibronectin 
increased the HERG1 current density. Blocking of HERG1 indeed impaired both co-
localization and co-immunoprecipitation of HERG1 and β1 integrins (Cherubini et 
al., 2005). In colorectal cancer cells HERG1 channels have been to shown to interact 
with β1 integrin and modulate signaling pathway involved in angiogenesis. The 
functional blocking of channels abolishes the pro-angiogenesis signaling both in vivo 
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and in vitro (Crociani et al., 2013). Expression of HERG1 in pancreatic cancer 
patients serves as prognostic factor and blocking of HERG1 channel in pancreatic 
cancer cells has shown to decrease proliferation and migration (Lastraioli et al., 
2015). The mounting evidences of involvement of many ion channels in cancer 
progression they are collectively viewed as potential drug targets in cancer.  
1.2.2. Ion channels as potential therapeutic drug targets 
Ion channels have long been the therapeutic targets in many 
pathophysiological conditions. There are many naturally occurring drugs or toxins 
that target ion channel with high affinity. The first synthetic ion channel modulator 
amylocaine a local anaesthetic was synthesized in 1903 that started a classic age of 
chemistry driven drug discovery and development. Ion channels are now the second 
most targeted class of proteins with ~ 13.4% of the marketed drugs targeting ion 
channels with worldwide annual sales worth $12 billion. These small molecule drugs 
are used for wide range of physiological conditions such as local anaesthetic, anti-
arrthymic, anti-hypertensive, anticonvulsant, diuretic, stroke, diabetic, cystic fibrosis, 
neuromuscular blocker/muscle relaxants etc. (Clare, 2010).  Despite the successful 
exploitation of ion channels, for their involvement in disease conditions, as potential 
drug targets, the currently targeted ion channels amount for only 20% of the 300 
members of ion channels that are expressed in human (combined healthy and disease 
conditions). Moreover, the roles of ion channels in vast number of human cancer 
progression are very well documented and serve as huge potential targets. With 
recent advances in drug designing, structural biology of ion channels and high 
throughput patch clamp screening for effect of drugs on ion channel modulation has 
increased the pace of drug discovery against non-targeted ion channels.  
The role of ion channels in vast number of human cancer has been studied 
since last 20-30 years. In most cancers ion channels are over or aberrantly expressed 
indicating their role in enhancing the tumor malignancy. Hence the over expressed 
ion channels are increasingly viewed as biomarkers for possible early diagnosis as 
well as oncogenes for potential drug targets. For efficient targeting of these ion 
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channels various drug-designing strategies have been employed namely small 
molecule drugs to block the ion permeation, full-length antibodies to target 
extracellular epitope or loop of the ion channels (Xu et al., 2005), fusion proteins 
consisting of single chain antibody fused to TRAIL ligand to induce cancer cell 
specific apoptosis, overexpression of ion channel targeting microRNAs (Feng et al., 
2014) etc. Plethora of evidence suggest that functional impairment of over expressed 
ion channels in cancer by blocking the channels with specific small molecule drugs, 
antibody targeting or silencing the channel expression by siRNA have remarkably 
decreased the tumor cell proliferation, migration, invasion in both in vitro and in vivo 
animal models.  
The table 1 below shows the summary of aberrant expression of only K+ ion 
channels with focus limited only to pancreatic cancer tissues and cells. Because of 
both the peculiar expression pattern of ion channels under pathological conditions as 
well as membrane expression make them easy to detect valuable biomarkers 
particularly for early diagnosis and perhaps also as potential drug targets as 
therapeutic strategy. 
Table 1. K+ ion channels expression in pancreatic cancer cells and their mode of 
action in promoting malignant features.   
Hallmarks of 
cancer 
Ion 
channel 
type 
Expressi
on level Modulators Mode of action 
Cell 
proliferation 
HERG1 Up regulated 
E4031  
E4031 decreased 
pMAPK cell signaling 
in K-Ras(mut) cell line 
(Lastraioli et al., 2015)  
miR-96  
Micro-RNA (miR-96) 
expression down 
regulates HERG1 (Feng 
et al., 2014a) 
Kv10.1  Up regulated 
Bifunctional 
scFv Ab 
Fusion protein targeting 
extracellular epitope of 
Kv10.1 and TRAIL that 
induces death of Kv10.1 
(Hartung et al., 2011)  
  
Introduction 
 
26 
KCa3.1 Up regulated 
Clotrimazole 
and TRAM-
34 
Decreases cell 
proliferation in 
expression dependent 
manner (Jäger et al., 
2004)  
Kv 1.5, 
1.1and 
1.3 
      
Cell migration 
/metastasis HERG1    
E4031  
Decreases the PDAC 
cell migration 
stimulated by pancreatic 
stellate cells and alters 
the actin dynamics 
through interaction with 
B1 integrin. 
miR-96 
miR-96 expression 
directly target HERG1 
and decreases cell 
migration of HERG1 in 
vitro and 
tumorgenecity, 
metastasis and HERG1 
expression in vivo 
models (Feng et al., 
2014b)  
Apoptosis 
HERG1 
  
siRNAs 
Silencing of HERG1 
expression increases the 
(%) cells that enter 
apoptosis (Feng et al., 
2014b). 
Kv10.1 Bifunctional Ab 
Antibody fusion protein 
containing extracellular 
epitope recognizing of 
Kv10.1 (scFv) and 
TRAIL that induces 
death of 
Kv10.1expressing 
tumor cells (Hartung et 
al., 2011). 
Prognosis HERG1     
HERG1 expression in 
PDAC tumor show poor 
prognosis (Lastraioli et 
al., 2015). 
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1.3. Integrins structure, function, activation, signaling 
cascades in cancer 
1.3.1. Integrins structure, function and activation 
Mammalian cells express wide range of cell adhesion molecules (CAMs) that 
aid anchorage of the cells either to ECM or to neighbouring cells. These CAM 
proteins are divided into calcium dependent or independent. Integrins are major class 
of CAMs that are calcium dependent. Integrins are large heterodimer transmembrane 
cellular receptor proteins made of alpha (α) and beta (β) subunits. In vertebrates there 
are 16 α and 8 β subunits that made up to 24 combinations of non-covalent 
heterodimer integrin receptors (Calderwood, 2004). Each integrin heterodimer is 
distinct in property of binding affinity and tissue distribution. The large extra cellular 
domain of each subunit is made up of many smaller domains called as ‘ectodomains’ 
that are held together by flexible linkers. The transmembrane domain is a single 
membrane spanning helix while the cytoplasmic domain of integrin is a small-
unstructured domain (Campbell and Humphries, 2011; Calderwood et al., 2013). The 
detailed structure of ectodomains of the integrins is reviewed by Campbell ID and 
Humphires MJ (Campbell and Humphries, 2011), below only the brief introduction 
of each of the domain will be explained.  
Although the entire crystal structure of integrin molecule is not solved yet, the 
breakthrough in the structure of integrins came when crystal structure of ectodomains 
of αVβ3 integrins was deciphered by Xiong et.al in 2001(Xiong et al., 
2001)Currently, the crystal structures of αVβ3, αIIbβ3 and αXβ2 are available. Below 
is the representation of αXβ2 integrin that has inserted α-I domain. The integrins are 
transmembrane proteins with large portion in extracellular domain and two smaller 
portions in transmembrane and cytoplasmic domain. (a) Extracellular domain: As 
shown in above scheme-6 of αXβ2 there are four-five ectodomains in alpha monomer: 
seven bladed β-propeller, a thigh and two calf domains in-that-order and the fifth 
domain, inserted between blade two and three of β propeller, is α-I domain present in 
only nine out of 18 α chains. The last three or four blades of β propeller binds Ca2+ 
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ions and influence the ligand binding. There are two main flexible regions in the 
ectodomains; one between the flexible linker is between β propeller and thigh and, 
the other is between thigh and calf1 domain. The αI domain is inserted in β propeller 
with linkers and shows higher flexibility in contrast to other domains and regulates 
the binding affinity. The β monomer chain of integrin however, on the other hand 
consists of more complex flexible and interactions. It consists of β-I domain, hybrid 
domain, plexin-semaphorin-integrin (PSI) domain, and four cysteine rich epidermal 
growth factor (EGF) domains (EGF1, EGF2, EGF3 and EGF4) followed by β tail 
domain closest to plasma membrane as shown in scheme 6. The β-I domain is 
homologues to α-I domain and inserted into the hybrid domain. The hybrid domain is 
in turn inserted in PSI domain that is split into two portions. A disulphide bond at 
Cys13 and Cys 435 connects the two portions of PSI domain. 
 Scheme-6. Adapted from Integrin Structure, Activation, and Interactions (Xie et al., 2010; Campbell 
and Humphries, 2011). The structure of αXβ2 integrin (Xie et al. 2009). 
The EGF domains, in αVβ3, consist of even number of eight cysteines, 
bonded in C1-C5, C2-C4, C3-C6 and C7-C8 except in EGF1, while in αIIbβ3 all 56 
cysteines were disulfide bonded in β3 subunit. Overall, it was observed that the β 
subunit was more flexible than α subunit. The cations are very essential for integrin 
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binding to ligands. The ectodomains of both α and β at the outer most domains 
consist of cation binding sites. The ligands bind to the crevice of the αβ interface (α-I 
and β-I domain). In the absence of α-I in integrins, ligand binding occurs between β-
propeller and β-I interface and the binding are dependent on cations like Mg2+, Mn2+ 
and Ca2+. However, in presence of α-I domain integrin ligand binding involves Mg2+ 
ion, a metal ion dependent adhesion site (MIDAS) (Shattil et al., 2010; Campbell and 
Humphries, 2011) (b) Transmembrane (TM) domain: TM domains were 
significantly smaller domains of integrins with single spanning structures of ~25-29 
amino acid that form α-helix. There are no currently available high-resolution crystal 
structure TM domains of any integrin and most of the structural data are from NMR 
analysis. The α and β subunits in TM are tightly packed through glycine-glycine 
interactions (Kim et al., 2011; Srichai M.B and Zent R, 2010). Studies involving 
electron microscopy (EM), disulfide cross-linking, activating mutations and FRET 
suggest that α and β subunits are associated in TM domain in inactive or bent 
conformation. Both the separate structures of αIIb and β3 subunits and complex 
structures solved by NMR both and in complex and, disulfide cross-linking of intact 
αIIbβ3 show similar structure. The αIIb helix is perpendicular to the membrane while 
β3 makes slightly tilted angle. (c) Cytoplasmic domain: Likewise with TM domain 
there are no high-resolution crystal structures available for the cytoplasmic domain. 
The cytoplasmic domain of the integrins are also relatively short with ~10-70 amino 
acid (except β4 with >1000 a.a). The cytoplasmic domain of β3 is highly homologous 
while the αIIb is highly divergent subunit (Srichai M.B and Zent R, 2010). The β 
subunit within cytoplasmic domain has two motifs; membrane proximal and 
membrane distal motif that serve as binding sites for integrin binding proteins like 
talin, kindlins etc which are critical for integrin activation from inside the cell.  
Integrins are the bridging molecules between extracellular environment 
(especially matrix proteins) and intracellular cytoskeleton. When integrins interact 
with specific sequences on the matrix proteins their conformation changes are 
induced along the length of the integrin. At the extracellular domain, the bent 
conformation of the integrin is changed to extended conformation, at the TM domain 
the α and β subunits are dissociated and lastly at the cytoplasmic domain the 
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conformational changes include unmasking of the protein binding sites, which are 
involved in either intracellular signalling or intermediate proteins to link integrins to 
actin. Integrins are linked to actin cytoskeleton through a complex hierarchy of 
proteins that form into a globular structure termed as adhesome. There are as many 
as 180 protein-protein interaction nodes in this structure defining the complexity and 
connectivity of the network (Parsons et al., 2010).  
Integrin activation: Firstly, the integrins are essentially expressed at the 
membrane in an inactive conformation. Integrins are not just receptor molecules but 
when activated they are also involved in both outside in and inside out signalling. 
However, because integrin lack tyrosine kinase activity the intracellular signalling 
occurs through the recruitment of non-receptor tyrosine kinase proteins to its 
cytoplasmic protein binding sites. Integrin is activated from both extracellular ligand 
binding in ectodomains (outside-to-in signalling) and intracellular integrin binding 
proteins at the cytoplasmic tail (inside-to-out signalling). Both outside-in and inside-
out signalling are dynamic spatial and temporal regulation of assembly and 
disassembly of multiprotein complexes that form at the cytoplasmic tail of integrins 
(Harburger and Calderwood, 2009). This integrin activation leads to a conformational 
change from bent to the extended heterodimer and dissociation of α and β subunits at 
the TM domain, a required conformational change shown for αIIbβ3 (Zhu et al., 
2007). 
1.3.2. Outside-in signalling role of integrins 
The extra cellular matrix (ECM) proteins bind to the α and β interface and the 
conformational changes are conveyed through TM domain to cytoplasmic domains 
where further conformational changes lead to integrin clustering and formation of 
focal adhesion sites. This outside-to-in signalling modulates wide range of signalling 
cascade that are involved in cell adhesion, proliferation, migration, cytoskeleton 
organization of actin, paxillin etc. Intriguingly, the involvement of integrin activation 
in these physiological processes is highly temporal dependent (Legate et al., 2009). 
For example when the integrins initiate the engagement with matrix, the integrins 
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recruitment of phospho tyrosine kinases like FAK, Src, RACK1 and paxillin to its 
nascent adhesion site is an early event (typically 0-10minutes of engagement), even 
upstream of integrin activators like talin. But when adhesion is more matured the 
talin is more engaged with integrins (Serrels and Frame, 2012). The subsequent effect 
of integrin engagement with matrix leading to actin cytoskeleton organization, 
spreading, cell polarity occurs typically in 10-60 mins while effects on gene 
expression, cell survival and differentiation is a long term effect (Legate et al., 2009).  
1.3.3. Integrins in cell adhesion signaling and migration 
1.3.3.1. Integrins in cell adhesion and signaling 
In cell adhesion, cells anchor to either the neighbouring cells or to ECM 
ligand with the help of cell adhesion molecules (CAMs) like integrins, cadherins and 
selectins. Integrins are the central part of the cell-matrix adhesion that is essential for 
normal physiological processes like embryonic development, wound repair, as well 
as during disease progression such as cancer. On the other hand ECM are large 
proteins and composite of various matrix molecules like glycoproteins fibronectin, 
collagen, laminin etc and non-matrix secreted cellular components like growth 
factors. Interestingly, within the ECM integrins recognize short peptide sequence 
residues, typically RGD (arginine-glycine and aspartic acid). However, not all RGD 
comprised peptide sequence can induce cell attachment; in fact out 2600 proteins 
sequences including fibrinogen, vitronectin, vol Willebrand factor etc that have RGD 
peptide only a minority of them do so. This may be due to RGD sequence is not 
always presented on the surface or not compatible for the integrins to bind (Ruoslahti, 
1996). Interestingly, it is the residues that are outside RGD motifs that provide the 
high affinity and specificity for ligand-integrin pair and these secondary sites are 
assumed to interact with the alpha subunit of the integrins while RGD peptide 
interacts with β subunit (Takagi, 2004). For example, α5β1 preferentially binds to 
RGD sequence when RGD is flanked by GW amino acid but αVβ1 has broader 
specificity (Mould et al., 2000) while some amino acids like proline if present outside 
RGD can inhibit the cell attachment (Ruoslahti, 1996).  
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Cell matrix adhesions are highly dynamic structures that are organized around 
cytoplasmic tail of clustered integrins. At the early stage of integrin activation by 
ligands, the FAK is recruited to the integrins at the FA by talin, an integrin activator 
(Serrels and Frame, 2012). FAK is one of the most significant integrin signaling 
molecules because it harbours multiple activation sites and interacts with various 
proteins. At N-terminus it has FERM domain (binding of protein 4.1, ezrin, radixin 
and moesin homoglogy), kinase domain (for multiple autophosphorylation sites) and 
FAT domain at C-terminus. FAK is recruited at the nascent adhesion (early stage of 
the adhesion) and auto-phosphorylated firstly at 397 a.a that leads the creation of the 
binding site for Src-homology2 (SH2) of Src. This binding in turn lead to cascade of 
phosphorylation, mainly initiated by SH2 domain of Src, along the FAK and 
interactions of FAK with other proteins that are essential in adhesion-dependent 
signalling (Kumar, 1998; Mitra et al., 2005; Huveneers and Danen, 2009). The FAK-
Src active complex phosphorylates other FAK associated proteins like paxillin, 
p130Cas and tensin (Kumar, 1998). At C-terminus FAK interacts with paxillin. 
During the course of adhesion maturation, however, the FAK is folded back and 
integrin is more associated with talin for stronger adhesion structures (Lawson et al., 
2012). To this end actin binding proteins like vinculin and α-actinin bind to talin and 
connect the ECM and cytoskeleton organization through integrins.  
In addition to FAK modulation, Rho family of GTPases (RhoA, Rac1 and 
Cdc42) are also regulated in integrin-mediated adhesion. RhoA, Rac1 and Cdc42 are 
the most thoroughly studied members of Rho family. RhoA when activated induces 
FAs and bundle of contractile actin and myosins called as stress fibers: while Rac1 
and Cdc42 stimulate the formation of two types of protrusions lamellipodia and 
filopodia (Kumar, 1998; Arthur and Burridge, 2001; Huveneers and Danen, 2009). 
That is to suggest that, Rac1 and Cdc42 are localized at the cell front but with distinct 
spatial and temporal sites while RhoA is prominently active in cell rear of the 
migrating cell. In the initial phase of adhesion and spreading (10-30mins) the active 
RhoA (GTP bound RhoA) level is transiently reduced and the levels of Rac1 and 
Cdc42 are elevated. At more mature stage of adhesion (45-90mins) the RhoA-GTP 
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level increases whereas the Rac1 and Cdc42 levels are decreased (Arthur and 
Burridge, 2001; Huveneers and Danen, 2009). There is also evidence of hierarchical 
interconnections within these family members where Cdc42 regulates Rac and, Rac 
in turn regulates Rho proteins (Kumar, 1998).  
1.3.3.2. Integrins in cell migration 
Integrins are hands and feet of the cell to grasp its extracellular environment 
and move along it. Cell migration is highly dynamic multifaceted phenomenon that 
requires that interaction between cell and substratum on which cell is attached and 
migrates. The migration can be either single cell or collective cell migration and 
unidirectional or random. In collective cell migration, the intercellular interactions 
and co-ordinations are retained. The single cell migration is further categorized into 
mesenchymal and amoeboid, though there are conflicting evidences that suggest 
nonmesenchymal cells well as amoeba-like dictyostellium can have mesenchymal 
like migration (Huttenlocher and Horwitz, 2011). Mesenchymal migration (for ex 
fibroblasts, cancer cells) involves cell polarization to form actin-rich protrusions at 
the leading edge, adhesion formation and maturation, cell body translocation and 
detachment of cell rear. This multifaceted dynamics involve strong interactions of 
integrins with substratum. Whereas, amoeboid like migration involve gliding and 
rapid migration (for ex neutrophils, dendritic cells, lymophocytes) and exhibit weak 
or no integrin mediated traction forces. Thus the level of expressions of integrins and 
ligands, their binding affinity, cytoskeleton association etc. regulates the migration 
rate and direction of migration. In general, the optimum migrations of cells in both 2-
D and 3-D occur at intermediate levels of expression of integrins like a5B1, a2B1 and 
ligands like fibronectin and collagen (Huttenlocher et al., 1996;  Huttenlocher and 
Horwitz, 2011).  
The structure of a typical migrating cell can be divided into three 
compartments; leading edge (consisting of lamellipodium, FA complexes, actin 
filaments), cell body and rear or trailing edge (consisting of actomyosin filaments). 
The FA complexes are formed when cells grasp to the ECMs and generate forces for 
the cells to move forward. At the leading edge the stabilization of nascent adhesion 
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leads to the activation of Rac and Cdc42 that in turn reinforce the actin 
polymerization at the leading edge and subsequent protrusion. When cells grasp to 
the ECM, the FA complexes are formed that lead to the stabilization of nascent 
adhesion and activation of Rac and Cdc42 that in turn reinforce the actin 
polymerization at the leading edge and subsequent protrusion. This step generates 
necessary force to pull the cells body forward at the leading edge (Nagano et al., 
2012). The cell movement is accompanied by the release of FA complexes, a process 
of disassembly, from the ECM and perhaps also internalization of integrins. As the 
lamellipodium moves forward the nascent adhesion has to disassemble. However, 
when nascent adhesions are connected with actomyosin in lamellum they mature and 
form larger focal adhesions that are accompanied by the localized activation of Rho 
(Parsons et al., 2010; Huttenlocher and Horwitz, 2011).  
When the integrins are clustered upon activation it recruits wide array of 
intracellular proteins to its cytoplasmic tail that link integrins to actin cytoskeleton. 
Although several molecules are implicated to link integrins and actin, most likely 
candidates that are involved in bridging are talin, vinculin and α-actinin. The linkage 
stabilizes the adhesion and disruption of any molecular linkers compromises the 
integrity of adhesions and lead to the disassembly. For example, talin is required for 
integrin activation and linking integrin with actin and stabilizing the adhesion. 
However, when a protease calpain binds to talin or talin knockout cell show unstable 
adhesions. Similarly, vinculin gene, which is involved in mature and stable 
adhesions, deletion increases cell migration. Finally, integrins with their unique 
ability to tune their affinity to ligands regulate the stability of adhesions (Vicente-
Manzanares et al., 2009). 
However, inside-out signalling is initiated by the dissociation of non-
covalently linked α and β subunits. Also several mutational studies to disrupt α and β 
subunits, which otherwise would have held both the subunits through salt bridge, 
have shown to activate integrin (Shen et al., 2012). There are various proteins that 
bind to the integrin and increase its affinity for ECM binding. Talin is a major 
integrin activating homodimer ~270kDa protein that bind to cytoplasmic tail of 
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integrin. Like integrin, talin is shown to be essential for normal development in mice, 
drosophila and c.elegans. Talin can strongly bind, its head domain, and activate 
broad range of β subunits like β1A, β1D, β2, β3, and β5 and increase its affinity to 
ECM proteins (Calderwood, 2004a). The activation of integrins from inside as well 
as outside governs some of the key cellular processes. They include cell adhesion, 
cell-cell interactions, cell-substratum interactions, cell proliferation, differentiation, 
migration and apoptosis. Within this broad range of cellular processes that involve 
integrins we mainly focus on cell adhesion, migration and cell signalling pathways in 
below section.  
1.3.4. Integrins in cancer 
Similar to ion channels mentioned in previous section, integrin expression 
patterns can vary considerably between normal and tumor tissues. Many integrins are 
up regulated in cancers that contribute to tumor progression by mediating migration, 
proliferation and survival of tumor cells summarized in review (Mizejewski, 1999). 
There are some integrins like a2b1 that are down regulated for ex in breast cancer 
and, over expression of a2b1 alleviates tumor growth (Zutter et al., 1995). Similarly, 
over expression of laminin-5 receptor, a3b1 integrin in skin carcinoma cells showed 
decreased tumor growth rate (Owens and Watt, 2001). Among 24 different 
heterodimer combinations of integrins, the most widely studied integrins that are 
associated with disease progression are aVβ3, aVβ5, a5β1, a6β4, a4β1 and aVβ6 
(Desgrosellier and Cheresh, 2010). The integrins however are not oncogenes per se 
as they do not have the capabilities of transforming the cells, but they cross talk with 
oncogenes and receptor kinases to enhance tumor promoting signaling cascade. 
1.3.4.1. Integrins expression: implications in pancreatic tumor 
progression 
1.3.4.1.1. Beta (β) 1 integrins 
The β1 subunit is the most extensively studied integrin subunit for its role as 
receptor signaling molecule in both normal and neoplastic cells. The β1 subunit 
makes heterodimer complex with the as many as 12 different α subunits and thus can 
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interact with most of the ECM ligands depending at varying affinity depending on the 
α subunit partner. Because various ECMs and β1 integrin expressions are up 
regulated in most of the pancreatic cancer tissue and cell lines their interactions are 
crucial for the progression of tumor at various stages (Grzesiak et al., 2007; Hall et 
al., 1991). The integrin β1 and ECM collagen are predominantly expressed in PDAC 
and PDAC cells. The characterization of integrin-ECMs interactions in several 
pancreatic cancer cells shows that collagen promotes maximal PDAC cell adhesion, 
proliferation and migration through α2β1 integrins (Grzesiak and Bouvet, 2006). 
Another study by the same group shows that the knockdown of β1 integrin in 
pancreatic cancer cell model decreased cell proliferation and migration in vitro and, 
primary tumor size and completely abrogated metastasis in vivo. Interestingly, β1 
knock down also reduced surface expression of its α subunit partners like α1, 2, 3, 5 
and V subunits (Grzesiak et al., 2011). Pancreatic stellate cells (PSCs) play a major 
role in both increasing the malignancy of tumor cells. The supernatant of PSCs 
stimulate α2β1 mediated PDAC cell migration, adhesion and activated FAK 
signaling. Both the anti- α2β1 antibody and inhibition of FAK diminished the effect 
of the PSCs (Lu et al., 2014; Mantoni et al., 2011). 
1.3.4.1.2. AlphaVBeta3 (αVβ3) and alphaVbeta5 (αVβ5) integrins 
Integrins autonomously regulate diverse signaling cascades in the cells. In 
addition, there is growing body of evidence that integrins and growth factor receptors 
interact at membrane-proximal level and regulate cell-signaling pathways involved in 
cancer cell adhesion, proliferation, migration and metastasis. For ex integrin αVβ5 
and EGFR cross talk enhances invasion and metastasis of pancreatic cancer cells 
through Src kinase dependent activation (Ricono et al., 2009). In another example, 
exogenous expression of β3 integrin in pancreatic cancer cell model lead to increased 
tumor growth and metastasis compared to cells lacking β3 expression. The study 
further reveals that β3 integrin is involved in enhanced anchorage-independent cell 
survival through αVβ3/c-Src oncogenic unit activation (Desgrosellier et al., 2009)
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2. AIMS OF THE PHD STUDY 
Scientists have been providing ever-growing evidence about the implications of ion 
channels and transporters in many pathological conditions including cancer. The group of 
pathological conditions that are due to impaired functioning of ion channels are termed as 
channelopathies. More often than not, most of the ion channels are aberrantly expressed in 
primary cancer and cancer cell lines but not in normal counter parts. In addition the 
expression of these ion channels are retained at various stages of cancer progression. Hence it 
is imperative to characterize their roles in diseases and progression of diseases. Evidence 
suggests that the membrane potential of most of the cancer cells are altered to more 
depolarized Vm. Potassium ion channels are the largest family of ion channels expressed in 
both normal and cancer cells and therefore could play vital role in regulating the cellular 
physiological process including cell proliferation, migration and cell-volume. Within the 
large class of potassium ion channels, human ether-a-go-go related gene 1 (HERG1) is a 
voltage-gated potassium ion channels Kv11.1 that is coded by gene KCNH2. The schematic 
representation of hERG1 channels is shown below. These hERG1 channels are normally 
expressed in heart. In heart, hERG1 channels are best known to be responsible for 
repolarizing the rapid delayed rectifier current (IKr) in cardiac action potential. Below is the 
schematic representation of hERG1 channels 
            
Scheme 7: HERG1 channels are made of four identical alpha subunits (left panel-
intracellular view), each with six transmembrane alpha helices (S1-S6) and cytoplasmic N and C 
terminus (right panel). The S4 helix is the voltage sensor and K+ ions are conducted through it.  
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However, hERG1 channels are also expressed in many tumor tissues and cell lines 
including PDAC cells but not in normal counter parts. Hence we aimed to study the 
following roles of hERG1 channels in PDAC cells.  
 
¾ Functional role of hERG1 channels in PDAC cell proliferation and the mechanism of 
modulating cell proliferation. 
 
¾ Interactions of hERG1 channels with other membrane proteins like EGFR and integrins.  
 
¾ Functional role of hERG1 channels in PDAC cell migration and its role in modulating 
cytoskeleton organization through interactions with integrins. 
 
 
  
Materials and Methods 
 
39 
3. MATERIALS AND METHODS 
3.1. Cell lines  
3.1.1. Pancreatic ductal adenocarcinoma (PDAC)  
PDAC cells included Panc1, MiaPaca2 and BxPC3 cells. The Panc1 and 
MiaPaca2 cells harbor mutation in KRAS and TP53, homozygous deletion (HD) in 
CDKN2A/p16 and wild type (WT) SMAD4, while BxPC3 cells harbor mutation in 
TP53, HD in SMAD4 and WT KRAS(Deer et al., 2010).  
3.1.2. Human pancreatic stellate cells 
Immortalized human pancreatic stellate cells (hPSCs or RLT-PSCs) were a 
kind gift from Dr Ralf Jesenofsky of Universitätsmedizin Mannheim, Germany. 
3.1.3. Model cell lines 
HEK293 and mouse fibroblast GD25 cells were used for the exogenous 
expression of hERG1 channels as model cell lines. Three GD25 cells; GD25WT, 
GD25β1A (stably transfected with β1A integrin) and GD25β1Tr (expressing β1 
integrin truncated at cytoplasmic tail) were used as model cell lines.  
3.2. Materials 
3.2.1. Cell culture medium 
Cell culture media used to grow various cells was dubleco’s minimum 
essential medium (DMEM) (Euroclone), RPMI 1640 (Euroclone) and DMEM-F12 
(Sigma Aldrich) medium supplemented with 10% fetal bovine serum. DMEM media 
was supplemented with 4mM of l-glutamine and RPMI with 2mM. RLT-PSC cells 
were cultured in DMEM-F12 medium with 10% FCS. The culture media were also 
sometimes supplemented with pencillin/streptomycin (penstrep) antibiotic and 
fungizone.  
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3.2.2. Extracellular matrix (ECM) proteins  
ECM proteins fibronectin and laminin were purchased from Sigma Aldrich, 
collagen-1 was purchased from Millipore, collagen-III and IV from BD bioscicence.  
3.2.3. Antibodies 
Following table below shows the antibodies that were used in various 
applications with dilutions and companies from which they are purchased.  
3.2.3.1. Primary antibodies 
Table 2. List of primary antibodies used in the study 
Antibodies 
name 
Expt Mol 
Wt 
(kDa) 
Company  Source Diln. Clonal 
Anti-
Phospho-
MAPK 
 
WB 
 
42/44 
 
Cell Signaling 
Technology 
 
Rabbit 
 
1:500 
 
Poly 
Anti-ERK1 WB 42/44 Santa Cruz Rabbit 1:500 Poly 
Anti-α-
tubulin 
 
WB 
 
55   
 
mouse 
 
1:500   
Anti-Phos-
AKT1/2/3 
 
WB 
 
62/56/
62 
 
Santa Cruz 
 
rabbit 
 
1:500 
 
Poly 
Anti-P85 of 
PI3K 
 
WB 
 
85         
Anti-
Phospho-
Tyr(Py20)  
 
WB 
Total 
p-tyr 
protei
ns 
 
Santa Cruz 
 
mouse 
    
Anti-
hERG1 
mAb 
 
IP 
   
 
In house 
 
 
mouse 
 
5µg/mg 
protein 
 
 
 
mono Anti-
hERG1-
alexa 488 
 
IF 
1:1000 dil. 
 
Anti-EGFR 
 
IP   
 
Santa Cruz 
 
rabbit 4µg/mg protein 
 
Poly 
Anti-EGFR WB 170 Santa Cruz Rabbit 1:500 Poly 
C54 (Anti-
hERG1) 
 
WB 
 
135/ 
155 
 
In house 
 
Rabbit 
 
1:1000 
 
Poly 
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RM-12 
(anti-
Beta1A) 
 
WB 
 
~110 
 
Immunological 
Sciences 
 
Rabbit 
 
1:1000 
 
Poly 
TS2/16 
(anti-B1) 
 
IP   
 
Biolegend 
 
Mouse 5µg/mg protein 
 
mono 
IF 5ug/ml 
FACS   
Anti-αVβ5 
(P1F6) 
 
IP     
Abcam 
 
 
Mouse 
3.75µg/mg 
protein 
 
 
mono IF 1:1000 
WB 1:1000 
FACS   
Anti-
αV(L230) 
 
WB      Mouse 
 
1:1000 
 
mono 
FACS 
Anti-FAK WB 125 Santa Cruz Rabbit 1:1000   
Anti-pFAK 
Y397 
 
WB 125 Cell Signaling Technology 
 
Rabbit 
 
1:500   
Anti-
Paxillin 
 
IF     
 
mouse 
 
1:1000   
WBÆ western blot, IPÆ immunoprecipitation, IFÆ immunofluorescence, FACSÆ 
fluorescence-activated cell sorting 
 
3.2.3.2. Secondary Abs 
Source Rabbit- 1:10000 dilutions anti-α rabbit-peroxidase in 0.1% Tween-
PBS (T-PBS). 
Source mouse- 1:5000 dilution anti- α-mouse peroxidase. 
HRP-conjugated streptavidin- 1:10000 dilutions. 
3.2.3.3. Secondary Abs with fluorescent dyes 
Source Rabbit: Cy-3 conjugated rabbit 2nd antibody 1:1000 diltion in 10% 
PBS-BSA. 
Source Mouse: Alexa-488 conjugate mouse 2nd antibody 1:1000 diltion in 10% PBS-
BSA. 
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3.2.4. Drugs 
HERG1 channel blocker E4031 and activator NS1643 were purchased from 
sigma and Enzo life sciences respectively.  
3.2.5. Surface biotinylating agent  
Hundred milligrams (in powder form) of Ez-link Sulfo-NHS-LC-Biotin was 
purchased from ThermoFisher. The powder was always freshly dissolved in ultrapure 
dd. H2O at 0.5mg/ml before use. 
3.2.6. Buffer solutions  
All the components of the buffer solutions were prepared in ddH2O unless 
mentioned otherwise.  
3.2.6.1. Phosphate buffered saline (PBS) 
PBS solution composition (1X) includes NaCl-8g, KCl-0.2g, 
Na2HPO4.2H2O-1.44g and KH2PO4-0.2g in 1L dd.H2O 
3.2.6.2. Lysis buffer  
Following table below shows the components of lysis buffer 
Table 3. Components of lysis buffer 
       Ingredients  Mol wt Quantity (vol) Final conc. 
NP40  10% in H2O 617 1ml 150mM 
NaCl 1.5M  (10X) 58.44 1ml 150mM 
Tris pH 8 (1M) 121.14 0.5ml 50mM 
EDTA 100mM pH 8.0 292.24 0.5ml 5mM 
NaF 100mM 41.99 1ml 10mM 
Na4P2O7 100mM 265.90 1ml 10mM 
Na3VO4   200mM 183.91 20µl 0.4mM 
H2O  5ml  
Total  10ml  
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3.2.6.3. Wash buffer   
Following table shows the components of wash buffer 
Table 4. Components of lysis buffer 
Ingredient Mol wt Quantity (vol) Final conc. 
NP40  10% in H2O 617 1ml 150mM 
NaCl 1.5M  (10X) 58.44 1ml 150mM 
Tris pH 8 (1M) 121.14 0.5ml 50mM 
EDTA 100mM pH 8.0 292.24 0.5ml 5mM 
Na4P2O7 100mM 265.90 1ml 10mM 
H2O  6ml  
Total  10ml  
3.2.6.4. Running buffer (5X) 
Tris 15g, glycine 72g and SDS 5g were dissolved in 1L of dd.H2O and stored 
in 4-8C.  
3.2.6.5. Blotting buffer  
Blotting buffer includes 3g of Tris and 14.4g of glycine in 800ml of ddH2O 
and 200ml of methanol. 
3.2.6.6. Buffers in calcium measurement experiments 
HEPES ringer Buffer 1.2mM Ca2+ (for 1L): Set pH at room temperature 
(250C) 7.568 that corresponds to pH~ 7.4 (at 370C).   
     Table 5. Components of HEPES ringer buffer 
Compound Stock Conc. 
(M) 
Volume (ml) Final Conc. 
(mM) 
NaCl 3 40.8 122.5 
KCl 1 5.4 5.4 
CaCl2 0.1 12 1.2 
MgCl2 0.1 8 0.8 
HEPES 2.38gm - 10 
Glucose 1.09gm - 5.5 
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3.2.6.6.1. Calibration buffers 
a. 5mM Calcium buffer (for 500ml) 
      Table 6. Components of 5mM Calcium buffer 
Compound Stock Conc.  
(M) 
Volume (ml) Final Conc. 
(mM) 
NaCl 3 20.4 122.5 
KCl 1 2.7 5.4 
CaCl2 0.1 0.277gm 5 
MgCl2 0.1 4 0.8 
HEPES 2.38gm 1.19 10 
 
b. 0mM Calcium buffer (for 500ml) 
Table 7. Components of 5mM Calcium buffer 
Compound Stock Conc. 
(M) 
Volume (ml) Final Conc. 
(mM) 
NaCl 3 20.4 122.5 
KCl 1 2.7 5.4 
EGTA 0.95gm - 5 
MgCl2 0.1 4 0.8 
HEPES 2.38gm 1.19 10 
3.3. Cell culture  
3.3.1. PDAC cells 
PDAC cells Panc1 and MiaPaca2 were cultured in DMEM media freshly 
supplemented with 4mM l-glutamine and BxPC3 cells in RPMI media with 2mM 
glutamine. All the cell culture media were supplemented with 10% fetal bovine 
serum (FBS) and cultured at 37C and 5% CO2 unless mentioned otherwise.  
3.3.2. Model cell lines-HEK293 and mouse fibroblast GD25 
The HEK293 and three GD25 cell lines (GD25WT, GD25B1A and 
GD25B1Tr) were culture as PDAC cells.  
3.3.3. Human pancreatic stellate cells (hPSCs) 
Immortalized hPSCs were cultured in DMEM-F12 media pre-supplemented 
with l-glutamine. The medium was freshly supplemented with 10% FBS. For hypoxic 
stimulation or activation, semi-to-fully confluent hPSCs were incubated at 37C in 
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serum-free DMEM media in hypoxic incubator (1% O2, 5%CO2) for not more than 
18h.  
3.3.4. Culture plate coating 
Culture plates were coated with extracellular matrix (ECM) proteins like 
fibronectin (FN), collagen-1 (col-1), poly-l-lysine (PLL) and bovine serum albumin 
(BSA). FN and col-1 were coated at final concentrations of 5µg/cm2 and 10µg/cm2 
(of surface area) respectively as per manufacturer’s instructions. PLL at 20 µg/ml and 
BSA at 0.25mg/ml. All the coating substrates were diluted in serum-free media and 
plated to cover the entire growth surface followed by incubation at 37C for 1h (BSA 
for 30mins). Cells were seeded on to the coated surface for various time periods 
(described below). 
3.4. Transfection 
3.4.1. Transient transfection (plasmid DNA): DNA transfection 
Panc1 cells were transfected with LifeAct-GFP plasmid using 
lipofectamine2000 as per the protocol. LifeAct-GFP plasmid besides coding for GFP 
protein also codes for a 17 amino acid peptide, at C-terminus of GFP, which binds to 
filament-actin. The transfected cells (GFP positive) were visualized for actin 
filaments using TIRF microscopy.  
3.4.2. Stable transfection  
HEK293 cells were transfected with pcDNA3.1 plasmid harboring genes 
coding for hERG1 potassium channel and antibiotic resistance gene against geneticin 
(G418). The transfection was performed by lipofecatamine 2000 as per Invitrogen 
protocol and cells were cultured under selection pressure by supplementing the 
culture media with G418 at 0.8mg/ml.  
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3.5. Cell proliferation assay 
The PDAC cell lines; Panc1, MiaPaca2 and BxPC3 cells were cultured in 
respective media as mentioned above. For cell proliferation assay, ~ 90% confluent 
cells were serum straved for 18-20hr to synchronize the cells in G0/G1 phase. On the 
day of assay, cells were detached by trypsinization and pre-treated with hERG1 
blocker at 40µM for 30mins at 370C. The excess E4031 was removed by 
centrifugation and cells were freshly resuspended in complete medium. The cell 
density was estimated by trypan blue manual counting. Ten thousand cells were 
seeded in to each well of 96 wells plate in 200 µl of final volume with E4031 and 
incubated for the duration of experiments. The cell proliferation and viability was 
estimated by trypsinizing the cells every 24hrs and manual counting using trypan 
blue exclusion method.  
3.6. Soft agar colony formation assay 
The clonogenic potential of cells was determined in soft agar assays. Cells 
were suspended in 2,5 ml of 0.35 % agar low melting point (Sigma) in DMEM 
medium containing 10% fetal bovine serum and plated on top of 3,5 ml of 0,5 % agar 
low melting point, in the same medium, in 60 mm culture dishes (1500 cells/dish). 
Wherever necessary, E-4031 (40μM) and hERG1-mAb (50-100 μg/ml) were added to 
the medium. Cells were then incubated fourteen days at 37°C in a CO2 humidified 
incubator. Colonies were visualized by staining with 2% methyele blue in 50% ET-
OH, images of the stained colonies were acquired and counted with ImageJ software.   
3.7. Cell adhesion assay 
The 96 wells plate was coated with 1µg of FN per well. For cell adhesion 
experiments on ECM proteins cells were detached by PBS-EDTA (5mM), pelleted 
and resuspended in serum-free DMEM medium. Ten thousand cells were seeded on it 
to study the time course of cell adhesion and the effect of functional blocking of 
hERG1 channel by E4031 on cell adhesion. During the time-course of adhesion, 
unattached cells were washed away with PBS and attached cells were fixed using 4% 
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para-formaldehyde (PFA) for 15´ at RT, washed three times of PBS. Fixed cells were 
stained by toulidine-blue at final concentration of 0.5% in PFA for 10´ at RT. Excess 
toulidine blue was washed way with PBS (at least 3 times) and stained cells were 
treated with 5% SDS for 10´ to recover the toulidine-blue. The absorbance was 
measured at 595nm and percentage of cell adhesion was estimated. 
3.8. Cell migration assay  
The cell migration work was performed as Secondment in collaboration with 
Prof. Albrect Schwab, University of Munster, Germany. The PSCs were hypoxically 
activated for not more than 18h in serum-free DMEM media. During the activation 
PSCs secrete large number of proteins like GFs, cytokines, col-1 and MMPs etc that 
stimulate Panc1 cell migration. In parallel, 12 cm2 T-flasks were coated with 
‘desmoplastic matrix cocktail’ (see table below) at incubated at 37C for 
polymerization. One milliliter of matrix cocktail was used to coat six T-flasks. 
Twenty five thousand Panc1 cells were resuspended in serum-free media, seeded on 
the coating and allowed to spread (1-2hr). The Panc1 cell migration was stimulated 
by replacing serum-free medium with conditioned medium of hypoxically activated 
PSCs. The cells were immediately treated with hERG1 blocker E4031 at final 
concentration of 40µM and time-lapse images were acquired using bright field 
microscope for 6hr with interval of 5mins. For the analysis of cell migration every 
second image (10minutes interval) of last 4 hours was considered. To track the cell 
migration path total of 25 images of each cell were painted using the software 
program Amira. 
Table 8. Composition of despmoplastic matrix 
Composition Concentration Volume Final concentration 
Percentage 
of matrix 
(%) 
RPMI 5x 52 g/L 200 µL 10.4 g/L   
HEPES 10x 100 mmol/L 100 µL 10 mmol/L   
NaOH  1 mol/L 4.8 µL 4.8mmol/L   
H2O - 397 µL -   
Laminin 1 mg/mL 40 µL 40 µg/mL 4.46 % 
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Fibronectin 1 mg/mL 40 µL 40 µg/mL 4.46 % 
Collagen IV 0.9 mg/mL 6 µL 5.4 µg/mL 0.602 % 
Collagen III 1.0 mg/mL 12 µL 12 µg/mL 1.34 % 
Collagen I 4 mg/mL 200 µL 800 µg/mL 89.15 % 
    1000 µl Total conc. 100% 897.4 µg/ml 
 
3.8.1. Cell migration analysis 
For quantification and tracking of 2D migration the Amira Imaging Software 
was used to label the circumferences of the cells as previously described (Fabian et 
al., 2012; Fabian et al., 2008). The individual cell contours were manually determined 
frame-by-frame over the entire migration movie, which then served as the basis for 
further analysis. Every other image of the time-lapse video was selected for analysis 
giving intervals of 10 min duration. The duration of the migration movie analyzed 
was between 2-6h. Usig a Java-based Plugin for ImageJ individual data files could be 
obtained for each segmented mPSC. This data file was then imported into Microsoft 
Excel and the following parameters were determined:  
Cell migration tracking and calculations of speed, distance, directionality,  
 
Definitions of Directionality. The directionality of migration is calculated by the 
translocation from start to end (y) divided by the total distance covered (d). Changes 
in the directionality can point toward difficulties in the cells steering capabilities.  
1) Migration velocity [μm/min]:   Calculated from the movement of the cell center 
per unit time.  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2) Translocation [μm]:   Defined by the distance from start to end position.    
3) Total path length [μm]:   Defined by the total distance covered (from start to end 
position) during the migration movie. Calculated from mean velocity multiplied with 
the duration of the movie in minutes.    
4) Directionality:   The ability of the cell to move in a direct line from A to B. 
Calculated by the translocation (start to end point) (y) divided by the total path length 
(d). Cells moving in a direct line give values close to “1”, whereas cells changing 
direction give lower values.    
5) Cell Area [μm2]: Defined by the projected area covered by the cell. Not applicable 
to cells followed/marked only with a dot (cell center).  
6) Structure Index [SI]: The structure index defines cell morphology. Spherical cell 
shape structures give values close to “1”, whereas values closer to “0” indicate a 
more star-shape and extended structure/morphology. SI was calculated as follows:  
SI= (4*π*A)/ƿ
2 
 
“A” is the area covered by the cell and ƿ is the perimeter of A.  
3.9. (Co)-Immunoprecipitation  
For all the (co)-immunoprecipitation experiments cells were seeded on the 
culture plates coated with substrates like ECM proteins, PLL or BSA (as mentioned 
above) and incubated for a mentioned duration of time. After the desired time period 
of incubation for cell attachment on substrates cells were gently collected by mild 
scraping and resuspended in ice cold PBS. Further cell pellet was gently resuspended 
in lysis buffer to lyse the cell membrane without lysing the nuclear membrane and 
incubated for 15-20mins on ice. Cell lysate was centrifuged at maximum speed for 
10mins at 4C and supernatant was collected. Total protein concentration was 
quantified using Bradford assay and 2mg of total lysate was considered for (co)-
immunoprecipitation step. Two mg of total lysate was subjected to pre-cleaning step 
by adding 25μl protein A/G agarose beads and incubated for at least 1.5h at 4C to 
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capture IgG type antibodies from the total lysates. The supernatant was collected and 
further subjected to overnight immunoprecipitation (IP) by specific antibodies against 
protein-of-interest. After overnight incubation the immuno-complex was captured by 
30µl of protein A/G agarose beads for 2hr. The agarose beads were washed for 3 
times in ice-cold wash buffer and 3 times in ice cold PBS followed by addition of 2 X 
lameli buffer (14µl) and boiled for 5mins at 95C. The supernatant was subjected to 
sodium dodecyl sulfate-protein agarose gel electrophoresis (SDS-PAGE) for desired 
period of time. 
3.9.1. Immunoprecipitation of surface biotinylation  
For biotinylation of surface proteins cells seeded on ECM etc were collected 
and washed in PBS as above. Cells were resuspended in sulfo-NHS-LC-Biotin 
(Thermo fisher) at 0.5mg/ml and gently agitated at room temperature (RT) for 
30mins. Excess biotinylating agent was removed and cells were washed 3 times with 
ice cold PBS. Cells were then lysed for 20mins on ice using lysis buffer (Tris-HCl 
20mM, pH 7.4, NaCl 150 mM, glycerol 10%, Triton X-100 1%, 
phenylmethanesulfonyl fluoride (PMSF) 1 mM, aprotinin 0.15 units/ml, leupeptin 
10mg/ml, NaF 100 mM, Na vanadate 2 mM). The total protein concentration 
estimation and subsequent steps of IP was followed as mentioned above.  
3.10. Sodium dodecyl sulfate protein agarose gel 
electrophoresis (SDS-PAGE) 
All the protein samples were loaded onto 7.5% SDS gel and subjected to 
SDS-PAGE for desired time period. Below is the composition of resolving gel and 
stacking gel. The protein electrophoresis was run in 1X running buffer of 650ml. 
Table 9. Composition of resolving and stacking gel 
Resolving gel Stacking gel 
Components 1 gel Components 1 gel 
dd. H20 3.4 ml dd. H2O 2.41 ml 
1.5M TRIS-HCL 1.75 ml 0.5M TRIS-HCl 1 ml 
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pH8.8 pH 6.8 
10% SDS 70 µl 10% SDS 40 µl 
Acrilamide/bis 1.75 ml Acrilamide/bis 530 µl 
10% APS 35 (70 µl) 10% APS 20 (40 µl) 
TEMED 3.5 (7 µl) TEMED 4 (8 µl) 
Total volume 7 ml Total volume 4 ml 
3.10.1. Western blot (WB)  
After protein electrophoresis the proteins in the gel were transferred onto 
PVDF membrane in blotting buffer under cold condition for 1hr at 100V. The PVDF 
membrane was then blocked with 5% BSA in T-PBS solution for 3hr at RT to cover 
the unspecific antibody binding sites on the membrane. The membrane was incubated 
ON with antibody of interest. The following day the membrane was washed with T-
PBS (15mins X 3 times) and appropriate secondary antibody conjugated with 
peroxidase enzyme was dissolved in 5% BSA in T-PBS for at least 45mins and 
washing steps were repeated as before. The membrane was then illuminated with 
ECL solution in dark room to reveal the protein bands transferred on the blotting 
paper. Re-blotting on the same membrane was performed after stripping the 
membrane with stripping solution (mild or strong stripping solution depending on the 
signal), blocking again with 5% BSA in T-PBS for 30’ and ON incubation of primary 
Ab.  
3.11. Fluorescence activated cell sorting (FACS) analysis 
FACS was employed to study the surface expression of integrin subunits like 
β1, β3 and αVβ5 integrins. Firstly, integrins were stimulated by seeding the cells on 
ECM proteins till cell spreading and cells were collected, washed with ice cold PBS 
three times and primary antibody against integrins were added for 30-45mins at RT. 
Excess/unbound antibody was removed, washed as above and secondary antibody 
was added for 30mins and washing step was performed again. The cells were then 
resuspended in PBS and subjected to FACS analysis for quantifying the % of cells 
expressing integrins at the membrane level.  
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3.12. Immunofluorescence (IF) 
Thin glass cover slips were ethanol and flame sterilized and coated with 
fibronectin (FN). The cells were seeded on the glass cover slips for the desired time 
period. The unattached cells were washed away with PBS and cells were fixed with 
4% methanol-free para-formaldehyde (PFA) for 15’ at RT. The excess PFA was 
removed and washed three more times with PBS. For staining the membrane 
proteins, cells were incubated with appropriate antibodies specific for membrane 
proteins of interest overnight at 4C or 1-2h at RT followed by incubation with 
secondary antibodies conjugated with fluorescent dye-Alexa488 or Cy-3 (see the 
table-2 list of antibodies and secondary antibodies and their dilution). For 
intracellular staining, cells were permeabilized with 0.01% Triton-X for 5’ at RT, 
washed with PBS. Cells were then blocked with 5-10% BSA in PBS solution for at 
least 90’ at RT, washed and incubated with appropriate antibodies or rhodamine 
conjugated phallodin (for actin). Cells were mounted in mounting solution containing 
DAPI for nucleus staining. 
3.13. Microscopy for image acquisition 
3.13.1. Confocal microscopy and Image analysis using Fiji software 
The fluorescent labelled cells were examined under confocal microscope 
Nikon Eclipse TE2000-U (Nikon). The images were captured at 512X512 pixels; 
objective used was 60X and numerical aperture 1.4. 
 Fiji software was used to (i) study co-localization between hERG1 and Beta1 
integrins. The images acquired using multi fluorescence channel confocal microscope 
was processed using built-in plugin coloc2, with default settings, to study the degree 
of co-localization between hERG1 and Beta1 integrins. (ii) The Fiji software was also 
used to estimate the number of focal adhesions of FAK and paxillin and their area 
(Horzum U et al., 2014).  
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3.13.2. Image acquisition for actin dynamics study using Total internal 
reflection fluorescence (TIRF) microscope  
Panc1 cells were transfected with lifeAct-GFP that binds the f-actin filaments 
without interfering with the dynamics of actin (Riedl et al., 2008). The inverted 
microscope was equipped with digital camera (Visitron), TIRF slider (TILL 
Photonics) and a 100x 1.45 oil immersion objective. The TIRF microscope was used 
to acquire images of cells stained for actin with lifeAct-GFP. The image acquisition 
was controlled by MetaVue program and time-lapse images were acquired every 
1second for two minutes (Nechyporuk Z.V et al., 2008).  
3.14. Actin dynamics analysis using Spatio-temporal image 
correlation spectroscopy (STICS) method 
To assess the actin dynamics, the time series of images (acquired by TIRF 
microscope) were analysed using the spatio-temporal image correlation spectroscopy 
method (Hebert B et al., 2005). Each image (1024x1024 pixels) has been divided into 
smaller non-overlapping regions of interest (ROIs) of 16x16 pixels. An immobile 
filtering method has been performed to delete the contribution of fluorescent 
immobile structures (same Hebert citation above). Frames t apart in time was then 
spatially correlated to obtain 2D Gaussian-like spatio-temporal correlation functions 
(CFs). By means of a non-linear least squares (asymmetric) 2D Gaussian fitting, we 
obtained the temporal evolution of the Gaussian peak position and width. If flow is 
present in the ROI, the displacement of the peak over time is directly related to the 
velocity (i.e. xp=-vxt and yp=-vyt). The diffusion coefficient is instead obtained from 
the increase of the Gaussian width over time (i.e. w=w0+4Dt). To determine the 
minimum velocity that the method is able to detect, we simulated movies (120 frames 
at 1Hz) of only diffusing particles (i.e. no flow) in 16x16 pixels frames, setting all the 
parameters according to the analysis of real data (i.e. the diffusion coefficient D was 
set 0.25 pixels2/frame and noise has been added to obtain a signal-to-noise-ratio 
(SNR) of ~ 8). The STICS analysis have been performed on these simulated data and 
the resulting detected velocity was vmin  All the obtained 
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velocities were then cleaned according to the threshold and used to build flow maps 
superimposed on the fluorescent images  
3.15. Calcium measurement (by VisiView program)  
The intracellular free calcium level was measured by treating the cells with 
free calcium binding dye Fura2 in 1ml (final conc. 3uM). Fura2 was mixed in either 
PSC conditioned medium or serum free DMEM medium and incubated for 30mins at 
37C. The excess Fura2 was removed and replaced with HEPES ringer buffer 
(containing 1.2mM CaCl2). The images were acquired for every 10 seconds during 
the entire course of the measurement. Intracellular calcium intensity was measured at 
340nm wavelength for Fura2 dye. The measurement was done in pre-warmed 
constant perfusion of HEPES ringer buffer. When the intensity (and ratio of 
340/380nm) was stabilized the perfusion was stopped and cells were treated with 
E4031 in HEPES ringer buffer for at least 10mins and the intensity was measured. 
When the intensity was stabilized then the perfusion was again started with 0mM 
Ca2+ calibration buffer supplemented with 20ul ionomycin until the Fura2 intensity 
was stabilized. Then the perfusion was switched to 5mM Ca2+ calibration buffer 
supplemented with 20ul ionomycin and intensity was measured till stabilization.  
3.16. Patch-clamp recording 
Membrane currents were recorded in the whole-cell configuration of the 
patch-clamp technique, at room temperature (about 25°C), by using a Multiclamp 
700A amplifier (Molecular Devices). Micropipettes (3-5 MΩ) were pulled from 
borosilicate glass capillaries (Harvard Apparatus), with a PC-10 pipette puller 
(Narishige). Series resistance was always compensated (up to approximately 80%). 
Currents were low-pass filtered at 2 kHz and digitized online at 10 kHz, with 
Digidata 1322A and pClamp 8.2 (Molecular Devices). Data were analyzed off-line 
with pClamp 8.2 and OriginPro 8.0 (Microcal Inc.). Pipette contained (in mM): K+ 
aspartate 130, NaCl 10, MgCl2 2, CaCl2 2, HEPES 10, EGTA 10, titrated to pH 7.3 
with KOH. During the experiments, cells were perfused with an extracellular solution 
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containing (in mM): NaCl 130, KCl 5, CaCl2 2, MgCl2 2, HEPES 10, Glucose 5, 
adjusted to pH 7.4 with NaOH. In this case, the K+ equilibrium potential (EK) was -80 
mV. When necessary, a high extracellular [K+] was applied to increase the amplitude 
of the currents measured at -120 mV. In this case, the NaCl and KCl concentrations 
were, respectively, 95 and 40 mM (EK = -30 mV). The activation curves for hERG1, 
hERG1Δ2-370, hERG1ΔC+RD and G628S were determined from peak tail currents 
(Itail) at -120 mV (for 1.1 s), following 15 s conditioning potentials from 0 mV to -70 
mV (10 mV steps). The time between consecutive trials in the same stimulating 
protocol was 4 s. The holding potential (VH) was 0 mV.  The activation curves for 
hERG1, hERG1-K525C and hERG1-R531C were obtained following a stimulation 
protocol similar to the one used by Zhang et al. From a negative holding potential 
(VH -80 to -120 mV), we applied 1 s test voltages (in 10 mV increments) every 15 s. 
The test voltages (Vt) varied from -60 to +40 mV, from -70 to +50 mV and from -30 
to +70 mV, respectively for hERG1, hERG1-K525C and hERG1-R531C. To elicit Itail 
the test voltages were followed by repolarisation to -50 mV. Currents were registered 
in the presence of 5 mM-extracellular K+. For each cell the peak amplitude of Itail 
obtained at the different test voltages was normalized to the maximum tail current 
(Imax). The relationship between normalized tail currents (Itail/Imax) and Vt was fit to a 
Boltzmann function. 
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4. Results and Discussion 
4.1. HERG1 channels are involved in PDAC cell 
proliferation and anchorage independent colony 
formation through MAPK/ERK signaling cascade 
4.1.1. HERG1 channels are expressed differentially in PDAC cells  
The three PDAC cells Panc1, MiaPaCa2 and BxPC3 cells were firstly 
characterized for the expression of hERG1 channels. The hERG1 expression was 
analysed for the mRNA levels by qPCR (figure1a), protein levels by 
immunoprecipitation (IP) of total lysate (figure 1b), surface expression of the hERG1 
channels by immunofluorescence (IF) (figure 1c) and hERG1 current by whole cell 
patch clamp (figure 1d). The Panc1 and MiaPaCa2 cells show several fold higher 
expression of hERG1 channels compared to BxPC3 cells (Lastraioli et al, 2014). 
 
Figure1. The characterization of hERG1 expression in PDAC cells. Panc1 cells show highest 
expression of hERG1, MiaPaca2 shows intermediate and BxPC3 cells show lowest expression of 
hERG1 channels. (Note: These data was taken from Lastraioli et al 2015 in which I am a co-author). 
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4.1.2. PDAC cell proliferation 
All three PDAC cell lines Panc1, MiaPaca2 and BxPC3 were used for 
studying the role of hERG1 channels in cell proliferation. The cell lines were serum 
starved for at least 18h to synchronize the cells in G0/G1 phase. Ten thousand cells 
were seeded per well in 96-well plate and treated with hERG1 channel specific 
blocker E4031 at 10µM, 20µM and 40µM concentrations. The cell proliferation was 
estimated every 24h by trypan blue exclusion assay as described in material and 
methods section. The effect of E4031 on cell proliferation was observed to be dose 
dependent and was also in direct co relation to the amount of hERG1 expressed by 
cells. The highest effect of E4031 was observed in Panc1 and MiaPaca2 cells at 72h 
at concentration of 40µM (figure 2). Hence in all subsequent experiments we used 
E4031 at 40µM concentrations unless mentioned otherwise.  
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Figure2. All three PDAC cells were treated with hERG1 channel specific blocker E4031 at different 
concentrations and cell proliferation was estimated by trypan blue method. The E4031 at final 
concentration of 40μM showed the highest decrease in proliferation of all three-cell lines. 
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4.1.3. PDAC soft agar colony formation 
We further studied the ability of these cell lines in colony formation in 
anchorage independent manner. Invasive cancer cells have the ability to survive and 
grow in anchorage independent manner during invasion. The role of hERG1 channels 
in aiding such process was tested in soft agar colony formation assay. Both Panc1 and 
MiaPaca2 cells were seeded at both 1500 and 3000 cells per 60mm dish and treated 
with E4031 (40μM). The cells were grown for two weeks and the effect of E4031 on 
colony formation was estimated by difference in number colonies formed. BxPC3 
cells, however, did not form any colonies at 1500 and 3000 cells/dish but when 
seeded at 10,000 cells/dish they formed colonies much fewer than Panc1 and 
MiaPaCa2 cells. Similar to the effect observed on cell proliferation, E4031 treatment 
significantly decreased the number colonies of formed in Panc1 and MiaPaCa2 cells 
but not in BxPC3 cells (figure 3).  
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Figure3. All three-cell lines were treated with hERG1 channel specific blocker E4031 during the 
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course of the experiments (2 weeks). The E4031 treatment significantly decreased the number of 
colonies formed by Panc1 and MiaPaCa2 cells (a and c). 
The cell proliferation and growth involves wide array of signaling cascades 
including KRAS/MAPK and AKT pathways that are reviewed extensively in (Durino 
RJ and Xiong Y, 2013). Interestingly, hERG1 channel coding gene KCNH2 is 
clustered in the signaling network together with KRAS and TP53 that is related to 
tumor growth and metastasis of pancreatic cancer (Zhou B et al., 2012). So we 
studied whether hERG1 channel was involved in MAPK/ERK and ATK signaling 
pathways in tumor cell growth. All three cells were treated with E4031 for three-hour 
in complete medium, total lysate was extracted and 15μg of total lysate was separated 
in SDS-PAGE. The E4031 treatment decreased the activation of MAPK/ERK 
pathway in accordance with cell proliferation. The significant decrease in 
MAPK/ERK pathway was observed only in Panc1 cells and pAKT pathway was not 
affected in any cells (figure3).  
 
Figure 4. All cell lines were treated with E4031 to study the effect on MAPK and AKT pathways. 
Western blot images (right) show the decrease in MAPK pathway only in Panc1 cells that is also 
represented as blot intensity (on left). AKT pathway was not affected in these cells.  
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4.2. Characterization of surface expression of integrins in 
pancreatic ductal adenocarcinoma (PDAC) cell lines  
There is growing evidence that several integrin expressions are up regulated 
(and some are also down-regulated) in most of the primary tumours and tumor cell 
lines. These integrins are involved in various steps of tumor progression and thus 
they are perceived to be potential drug targets (Desgrossellier J.S and Cheresh D.A, 
2010). The tumor cells switch the expression of several integrins during tumor 
progression and retain some integrins, due to the selection pressure exerted by the 
host on the genetically unstable cancer cells. For ex, neoplastic cells lose some of the 
integrins that secure the adhesion and retain the integrins that are involved in cell 
survival, migration and proliferation (Guo W and Giancotti F.G, 2004).  
So we aimed to characterize the surface expression of β1 and αVβ5 integrins 
in Panc1 and BxPC3 cells seeded on various ECM. All the confocal images presented 
henceforth were taken with the collaboration of Dr Matteo Lulli, University of 
Florence. The study of surface expression of these integrins was performed by 
fluorescent assisted cell sorting (FACS) analysis, immunofluorescence and IP of 
surface biotinylated proteins. The cells were seeded on ECM coated dishes until cells 
were attached and spread. In the FACS analysis, cells were stained for specific anti-
integrin antibodies at room temperature (RT) followed by secondary antibody. The 
cells were then subjected to FACS and mean fluorescence intensity (MFI) for each 
integrin was quantified against only secondary antibody stained cells. Figure shows 
the MFI of β1 and αVβ5 integrins in Panc1 and BxPC3 cells seeded on ECMs. To our 
surprise, we observed (i) lower MFI for β1 and αVβ5 integrins in Panc1 cells and (ii) 
higher MFI for αVβ5 integrins in BxPC3 cells. Because, researchers have shown that 
β1 and αVβ5 integrins are highly expressed in Panc1 cells and αVβ5 is poorly or not 
expressed in BxPC3 cells (Grzesiak J.J and Bouvet M, 2006).   
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Figure5. The surface expression of B1 and aVb5 integrins was quantified by FACS analysis in Panc1 
and BxPC3 cells seeded on various ECM. 
To confirm the above observation on MFI of integrins in Panc1 and BxPC3 
cells we performed immunofluorescence experiments on Panc1 and BxPC3 cells and 
observed differential expression of various integrins as above. Both Panc1 and 
BxPC3 cells showed strong surface expression of β1 integrins whereas αVβ5 
integrins were moderately stained in Panc1 cells and very poorly stained in BxPC3 
cells. The fluorescence intensity of integrins showed more diffused signal when cells 
were seeded on FN due to the largely spread cell surface area compared to round cells 
on PLL where the signals were more concentrated (figure 6A). So we quantified the 
corrected total cell fluorescence (CTCF) signal considering the surface area of the 
cells. The CTCF values demonstrate that integrin activation by FN leads to highly 
increased membrane trafficking of integrins compared to PLL (figure 6b). We further 
biotinylated the surface proteins and immunoprecipitated with appropriate antibodies 
against integrins. Panc1 cells showed similar enhanced level of surface expression in 
β1 but surprisingly we observed an enhanced surface expression of αVβ5 when 
seeded on FN in contrast to PLL (figure 6c). The discrepancies we observed in the 
surface expression of integrins, in spite of employing same anti-integrin antibodies, 
could be because of the experimental protocol dependent for ex, staining of fixed 
cells (for IF) and staining the detached cells in suspension (FACS). So conclude that 
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at the total protein level β1 was highly expressed in both Panc1 and BxPC3 cells and 
αVβ5 only in Panc1. 
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Figure 6. Characterization of surface expression of integrins β1 and αVβ5 in Panc1 and BxPC3 cells. 
The surface expression of these integrins was greatly enhanced when cells were seeded on fibronectin 
in contrast to cells seeded on PLL. The immunofluorescence images of cells stained for β1 and αVβ5 
integrins (a) were used to quantify the corrected total cell fluorescence (CTCF) for each of the 
integrins (b). The IP experiments of surface biotinylated proteins in Panc1 cells also showed enhanced 
localization of surface integrins when cells were on FN (c).  
4.3. HERG1 channels make macromolecular complex 
formation with EGFR and integrin subunits  
We further aimed to study the interactions between hERG1 channels and 
membrane receptors like integrins and EGFRs. In almost all cancers it is well 
established that there is an up-regulation of wide range of membrane proteins like ion 
channels, growth factor receptors and integrin receptors that play a role in promoting 
tumor growth. Ion channels are transmembrane proteins that form the pores on the 
cell membrane for the easy passage of ions across the membrane. Due to the 
strategically membrane localization of these channels and ability to conduct ions 
across the membrane they are implicated to play key role in wide range of cellular 
activity including tumor promoting cell signaling pathways in proliferation, invasion, 
angiogenesis, migration, invasion and metastasis in addition to cellular physiology. 
These activities are more often carried out through the interactions with other 
membrane proteins like growth factor receptors (Rosen L.B and Greenberg M.E, 
1996; Pillozzi S et al., 2007), G-protein coupled receptors (Altier C and Zamponi C, 
2011), integrins (Pillozzi et al., 2007; Crociani O et al., 2013) etc. For example, 
hERG1 channels interact with β1 integrins and promote the signaling cascade in 
angiogenesis in colorectal cancer (Crociani et al. 2013). Similarly EGFR has been 
shown to interact with β1 integrin and αVβ5 integrins to promote tumorigenic 
properties in lung (Morello V et al., 2011) and pancreatic cancer cells (Ricono J. M et 
al., 2009) respectively. In the above studies we have shown the hERG1 channels 
modulate MAPK pathway, perhaps through interactions with EGFR. So firstly, we 
investigated the complex formation between hERG1 and EGFR in PDAC cells in 
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10%FCS supplemented medium. In the PDAC cells Panc1 and MiaPaca2, hERG1 
channels co-immunoprecipitate (co-IP) with EGFR (figure 7a). Similar complex 
formation was also observed when co-IP was performed on three different primary 
PDAC samples (figure 7b). In addition, immunohistochemistry (IHC) on the same 
primary PDAC tissue sections reveals the co-expression of hERG1 and EGFR (figure 
7b right panel). We further tested the role of E4031 in hERG1-EGFR complex 
formation and observed that E4031 did not interfere with complex formation (data 
not shown).  
Secondly, we investigated whether hERG1 channels make complex with 
integrin subunits. As described in above section, we characterized the expression of 
various integrins in PDAC cells and observed that β1 and αVβ5 integrins are highly 
expressed in Panc1 cells while BxPC3 cells do not express high αVβ5 and hERG1 
channels. So for further experiments we considered only Panc1 cells (and BxPC3 
cells wherever necessary as a negative control). The co-IP experiments included the 
stimulation of integrins by appropriate ECM like fibronectin, collagen-1, vitronectin 
and non-stimulant coating of poly-l-lysine (PLL as a non-integrin mediated 
adhesion). Cells were seeded on these matrix proteins till cells showed spread 
morphology (typically 60mins). The co-IP experiments were performed using 
appropriate antibodies as explained in methods section. HERG1 was observed to co-
IP with β1 integrins in all stimulation conditions including serum medium, but 
interestingly, under non-stimulating conditions like PLL hERG1 did not co-IP with 
β1 integrin (figure 7c). In addition, hERG1 also makes complex formation with αVβ5 
in both stimulation and non-stimulation conditions (figure 7d). Thus in summary 
hERG1 channels make macro molecular complex with EGFR, β1 and αVβ5 integrins. 
However, hERG1/β1 complex formation occurs only when β1 integrins is stimulated 
by ECM proteins as shown in scheme 8.  
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Figure 7. Co-immunoprecipitation of hERG1 with EGFR in PDAC cell lines (a) and PDAC primary 
cells and tissue samples (b). HERG1 channels also co-IP with β1 (c) and aVβ5 integrin (d). 
 
Scheme 8. Summary of the macro molecular complex formation of hERG1 channel with EGFR and 
integrins under activation (left panel) and non-activation conditions (right panel).  
 We further pursued our interests in characterising the interactions between 
hERG1 and β1 integrins in Panc1 cells. Cherubini et al have shown that hERG1 and 
β1 integrin interactions is two-fold; integrin activation increases the conductance of 
hERG1 channels while the functional blocking of the channel has shown to mitigate 
the integrin mediated signaling, namely activation of FAK in hERG1 transfected 
HEK293 cells (Cherubini et al 2005). With this observation we aimed to study the 
membrane co-localization of the hERG1 and β1 integrin in Panc1 cells seeded on 
fibronectin and poly-l-lysine (PLL) and treated the cells with hERG1 specific blocker 
E4031. Panc1 cells adhered on fibronectin and assumed spread morphology through 
the engagement of integrins while on PLL cells were attached with round shape. The 
immunofluoresence (IF) was performed to observe the co-localization of hERG1/β1 
in Panc1 cells. The β1 integrin stimulation by fibronectin showed strong co-
localization between hERG1 and β1 integrins (figure 8a) but functional blocking of 
hERG1 channels with E4031 treatment for 24hrs hERG1/β1 co-localization was 
significantly diminished (figure 8b). Similarly when β1 integrins were not stimulated 
on PLL we observed diminished-to-poor co-localization in both untreated (figure 8c) 
and E4031 treated cells (figure 8d). 
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Figure 8. HERG1 and β1 co-localization in Panc1 cells seeded on fibronectin without hERG1 blocker 
treatment (a), treated with hERG1 blocker (b) and on PLL, without blocker (c) and with blocker (d).  
The degree of co-localization of hERG1/β1 was further quantified using Fiji 
software with built-in plugins. The analysis provides Pearson and Manders’ co-
localization values shown in table below. The values represented are the average 
values of at least 10 cells from three independent images. Manders’ values tM1 and 
tM2 with threshold shows that hERG1/β1 co-localization was strongest in Panc1 cells 
that were not treated with E4031 (control) and seeded on FN (control). The E4031 
treatment as well as cells on PLL showed drastic decrease in co-localization.  
Table 10. The Pearson and Manders’ co-localization R-values in hERG1- β1 co-
localization 
    FN-control FN+E4031 PLL-control PLL+E4031 
Pearson R 
value 
(above 
threshold) 
  0.43±0.070 -0.09±0.111 0.19±0.025 0.363±0.089 
Manders’ value  
Without 
thresholds 
M1  (β1) 0.997 1.000 1.000 0.999 
M2  
(hERG1) 0.979±0.006 0.976±0.010 0.938±0.031 0.748±0.036 
With 
thresholds 
tM1  
(β1) 0.972±0.005 0.581±0.203 0.562±0.142 0.549±0.079 
tM2  
(hERG1) 0.960±0.012 0.499±0.180 0.384±0.053 0.199±0.039 
 
 a                                  b             c           d 
  
Results and Discussion 
 
68 
4.3.1. The hERG1 intracellular domains are not necessary for hERG1/β1 
interaction 
After studying the functional role of hERG1 channels and activation of β1 
integrins in the complex formation, we investigated the molecular domains within 
these proteins that could be involved in the complex formation. To this purpose, we 
used three variants of hERG1 channels; WT hERG1, N-terminus deleted hERG1 
(hERG1Δ2-370) and C-terminus deleted hERG1 (hERG1ΔC+RD). The hERG1Δ2-
370 lacks the entire N-terminus domain while hERG1ΔC+RD lacks c-terminus 
except for the Recapitulation Domain (RD) that allows the hERG1 channels insertion 
into the plasma membrane. All three variants were stably transfected in HEK293 cells 
and hERG1 current was measured.  
Figure 9A shows representative currents expressed by the two mutants. As a 
control, we used HEK-hERG1 cells, as indicated. In agreement with previous reports, 
hERG1Δ2-370 displayed the typical faster deactivation conferred by N-terminus 
deletion (Villoria C.G et al., 2000), whereas hERG1ΔC+RD generally expressed 
current amplitudes considerably smaller than the controls’ (Kupershmidt S et al., 
1998). Cells expressing either hERG1 or hERG1Δ2-370 were immunoprecipitated 
with either anti- dy (figure 9B, left), or the anti-hERG1 monoclonal 
antibody (figure 9B, middle). Cells expressing hERGΔC+RD were instead only 
immunoprecipitated with the anti-hERG1 monoclonal antibody (figure 9B, right). 
Both the N-deleted and the C-
extent as hERG1. The average densitometric results are shown in figure 9C. These 
results suggest that the cytoplasmic hERG1 domain is not critical for assembly with 
β1. 
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Figure 9. HERG1 currents measured in HEK-hERG1 cells stably transfected with the 
indicated constructs. (B) Representative co- -hERG1, HEK-
hERG1Δ2-370 and HEK-hERG1ΔC+RD cells, obtained by using the indicated antibodies. The 
average densitometric values obtained from 4 independent experiments are shown in the right panel. 
For each condition, the intensity of the band relative to co-IP hERG1 or β1 was, respectively, 
normalized to the intensity of the band corresponding to immunoprecipitated β1 or hERG1. For easier 
inspection, the value obtained on HEK-hERG1 cells was set to 1. (Note: This work has been submitted 
for publication in Science signaling, Becchetti A et al., in which I am a co-author) 
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4.3.2. The C-terminal (cytoplasmic) domain of β1 integrin is not 
implicated in hERG1/β1 interaction 
To study whether the β1 intracellular domain (i.e. the C-terminus) is directly 
implicated in the interaction with hERG1, we used the following constructs (Fig. 
11A): i) wild type β1 (β1), ii) β1 lacking the C-terminus (β1-extra) and iii) the β1 C-
terminus linked to the transmembrane and extracellular portions of the interleukin-2 
receptor (β1-cyto). These constructs were labelled with YFP, and transfected into 
 (Fässler R et al., 1995). The efficiency of 
transfection was evaluated by WB with anti-YFP antibodies (figure 11B). Cells were 
then transiently co-transfected with hERG1 and co-IP was performed with the anti-
hERG1 monoclonal antibody. Figure 11C shows that both WT β1 and β1-extra 
integrin co-immunoprecipitated with hERG1, whereas β1-cyto did not. We conclude 
that the cytoplasmic β1 integrin domain is not necessary for the complex with hERG1 
to form, and the interaction between hERG1 and β1 likely takes place between their 
transmembrane domains.  
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Figure 10 (A) Scheme of the β1 constructs used in these experiments: β1, β1-extra, and β1-cyto 
(defined in the main text). (B) WBs of total cellular lysates from GD25 cells transfected with the three 
constructs, and decorated with anti-YFP antibodies. The upper arrow indicates the expected 
molecular weight of YFP-conjugated β1 and β1-extra (approximately 127 KDa). The lower arrow 
indicates the expected molecular weight of β1-cyto (67 KDa). The band around 75 KDa and the thin 
bands between 130 and 150 KDa can be attributed to non-specific signal. (C) Co-
in GD25 cells transfected with the three constructs and transiently co-transfected with hERG1. The 
anti hERG1 Mab was used for immunoprecipitation, and WB was revealed with the anti-YFP 
antibody. Membrane was reprobed with the anti C-terminus hERG1 polyclonal antibody. The upper 
arrow on the left indicates the bands of β1 and β1-extra (lanes 1 and 2). In lane 3 (relative to β1-cyto-
transfected GD25 cells) no 67 KDa band is visible (dotted arrow). The IgG bands (50 KDa) are 
evident in all lanes, although at different intensities. Blots are representative of three independent 
experiments. 
4.3.3. The hERG1/β1 complex assembly depends on the channel 
conformational state. 
We tested the macromolecular complex formation by using two voltage 
sensor (S4 domain) hERG1 mutants (K525C and R531C) with different steady state 
activation properties. Representative current traces recorded from hERG1-K525C 
channels are shown in figure 11A (left panel). Compared to hERG1 wild-type (WT), 
the amount of hERG1-K525C protein expressed onto the plasma membrane and the 
maximal current density were generally lower (figure 11B), while the activation 
curve was strongly shifted to more negative Vm (figure 11C). In agreement with 
literature (43), the estimated V½ was -55 mV, and the measured resting Vm was -56 ± 
1.5 mV (n= 9). This suggests that, at the steady state, hERG1-K525C channels spend 
approximately 50% of the time in the open state. The same analysis was carried out 
for hERG1-R531C. Typical current traces are shown in (figure 11A) and the maximal 
current density of hERG1-R531C was similar to the WT’s (figure 11B). The 
activation curve was dramatically shifted to positive Vm (figure 11C), with an 
estimated V1/2 of +35 mV. The corresponding resting Vm was -42 ± 2.6 mV (n=15), 
implying that hERG1-R531C channels essentially reside in the closed state in HEK-
hERG1-R531C cells. 
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Figure 11D shows a representative co-IP test of the above channel types with 
E1 integrin. The densitometric analysis of four similar experiments is reported in the 
histogram of figure 11E (grey bars). Assembly with β1 was facilitated in hERG1-
R531C, compared to hERG1, whereas the opposite applies to hERG1-K525C. These 
results suggest that the E1/hERG1 complex formation is favoured when the channel 
spends most of the time in the closed state. To confirm this hypothesis we measured 
the amount of hERG1 co-immunoprecipitating with E in cells seeded onto FN in low 
extracellular K+ (control) and high (130 mM) extracellular K+. In the latter condition, 
the measured resting Vm was +19.6 ± 1.1 mV (n=9), at which WT channels are 
substantially removed from the closed state. Figure 11F shows representative co-IP 
tests in these conditions. The corresponding densitometric analysis is shown in figure 
11G. Complex assembly in the presence of high extracellular K+ was significantly 
lower than observed in standard low K+ medium. From this study on characterization 
of hERG1/β1 complex formation we conclude that hERG1 and β1 interaction (i) 
depends on the activation of β1 integrins on FN (ii) is impaired when the hERG1 
channels are blocked (iii) do not occur through cytoplasmic domain but through 
transmembrane domain and (iv) depends on the channels’ conformational state.  
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Figure 11. Analysis of the hERG1/ Typical whole-
cell current traces elicited in HEK cells stably transfected with either hERG1-K525C or hERG1-
R531C. Currents were recorded in 5 mM extracellular [K+]. (B) Comparison of the maximal current 
densities of hERG1, hERG1-K525C and hERG1-R531C cells. Data are average peak tail current 
densities calculated from at least 5 cells. (C) Activation curves of hERG1, hERG1-K525C, and 
hERG1-R531C cells. Data points are normalized peak tail currents calculated from experiments as in 
A). (D) Co-IP of β1 and hERG1 in cells expressing hERG1, hERG1-K525C, hERG1-R531C and 
seeded onto FN for 90 min. The experimental procedure was as described in the legend to Fig. 6) Grey 
bars summarize densitometric results obtained in three independent experiments. (F) Co-IP of β1 and 
hERG1 in HEK-hERG1 cells laid onto FN for 45 min in two different Tyrode solutions containing BSA 
(250 μg/ml): 1) low extracellular K+ (5 mM); 2) high extracellular K+ (130 mM, substituting the Na+). 
Immunoprecipitation was performed as described in the legend to Fig. 6. (G) Bars summarize 
densitometric analysis corresponding to the low and high K+ conditions, obtained in three independent 
experiments. The band intensities were normalized to the intensity of the band corresponding to 
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immunoprecipitated β1-integrin. (Note: This work has been submitted for publication in Science 
signaling, Becchetti A et al., in which I am a co-author). 
4.4. HERG1 channels are involved in integrin mediated 
PDAC cell migration and actin organization  
4.4.1. HERG1 channels are involved in PDAC cell migration on basement 
membrane. 
After characterizing the interactions between hERG1 channels and β1 
integrins we aimed to study the role of hERG1 channels in integrin mediated cell 
migration, adhesion and cytoskeleton organization. The potential of any transformed 
cells to become malignant and invasive is their ability to dissociate from the confined 
region within the basement membrane (BM). The BM is a thin dynamic structure 
composed of ~50 glycoproteins including ECM like collagen-iv, laminin and 
fibronectin produced jointly by epithelial, endothelial and stromal cells to separate 
epithelium or endothelium from stroma and stromal cells secreted interstitial matrix 
(Lu P et al., 2012). The invasive cells show the ability to migrate along the BM, 
remodel or degrade the structure through enzymatic degradation and escape to the 
more dynamic tumor microenvironment (TME), where the tumor progression is 
regulated by non-cell autonomous processes regulated by paracrine or juxtacrine 
interactions from the TME (Watnick R.S, 2012). We tested whether hERG1 channels 
are involved in PDAC cell migration on BM. The hERG1 channels blocking by 
E4031 decreased the cell migration of Panc1 cells significantly (p<0.05) compared to 
statistically less significant in MiaPaCa2 (p<0.02) and BxPC3 cells (p<0.01) (Figure 
12 Lastraioli et al. 2015).  
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Figure 12. All three PDAC cells were tested for the effect of E4031 on cell migration. E4031 treatment 
showed significant inhibition of cell migration only in Panc1 cells. (Note: This data was taken from 
Lastraioli E et al, 2015, in which I am a co-author). 
Cell migration is a five-step phenomenon that has been summarized as (i) 
extension of the leading edge, (ii) cell adhesion to the ECM, (iii) contraction of the 
cytoplasm (iv) release from the focal adhesion sites and (v) recycling of the 
membrane receptors (like integrins) from the rear to the front of the cell (Sheetz M.P 
et al., 1999). These steps involve tightly coordinated interactions between ECMs, 
integrins and the cytoskeleton proteins. In the subsequent studies we aim to 
investigate the role of hERG1 channels in modulating cell adhesion, adhesion 
dependent interactions with integrins and signaling pathways and actin cytoskeleton 
organization and finally calcium signaling that regulate the components of 
cytoskeleton among many other proteins.   
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4.4.2. HERG1 channels are not involved in cell adhesion on fibronectin 
Integrins are one of the most prominent receptor molecules that aid the cells to 
adhere to its extracellular ligands. We investigated whether hERG1 channels 
interaction with β1 integrins can influence the cell adhesion on fibronectin. 
Endogenous hERG1 expressing PDAC cells as well as stably transfected hERG1 in 
HEK cells were used for this study. The time course of adhesion of these cell lines 
show that the percentage of cells attached on fibronectin was not different between 
the cells that were treated with or without hERG1 blocker. Similar observation was 
also made between hERG1 expressing and non-hERG1 expressing HEK cells (figure 
13).  
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Figure 13: Cells were seeded onto fibronectin for the mentioned time points, fixed and stained with 
toluidine- blue as mentioned in methods section. The attached cells were quantified as % of control 
cells. The hERG1 blocking by E4031 treatment in PDAC cells and over expression of hERG1 in 
HEK293 cells did impact the cell adhesion.  
 
4.4.3. HERG1 channels make macromolecular complex formation with β1 
and FAK at the early stage of cell adhesion.  
Integrins, when engaged with ECM, are in principle involved in two sets of 
functions; (i) the wide array of signaling cascades that are associated with cell 
proliferation, gene expression, survival etc. and (ii) assembling the cytoskeleton 
remodelling that include actin and actin binding proteins that bridge actin and 
integrins (Ross R.S, 2004). Since integrins do not possess the enzymatic activities the 
signaling is mainly carried through focal adhesion kinase (FAK). Upon integrin 
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engagement with ECM FAK is auto-phosphorylated first at 397th amino acid residue 
tyrosine and this leads to the cascade of phosphorylation along the FAK and other 
adhesion dependent protein interactions (Kumar CC, 1998). FAK is also one of the 
first proteins that are recruited to the cytoplasmic tails of integrins during the nascent 
adhesion. However, as adhesion matures the FAK rolls back and is no longer engaged 
with integrins. In fact integrin has been shown to co-immunoprecipitate with integrin-
linked kinase (ILK) instead of FAK at later stages of adhesion (Hannigan G.E et al., 
1996). This observation prompted us to perform the time course of co-IP between 
β1/FAK and β1/hERG1 in Panc1 and HEK293-C5 cells seeded on FN. The time 
requirement for the FAK recruitment to the cytoplasmic tail of the β1 integrin after 
activation was distinctive between HEK293-C5 and Panc1 cells. The β1-FAK 
complex formation was at the peak only after 5mins of stimulation with FN in Panc1 
cells while in HEK293-C5 cells it was at 30mins. The association between β1/FAK at 
later intervals decreased significantly (figure 14). Interestingly, the β1/hERG1 
complex formation also followed a similar trend for both the cells suggesting that 
β1/FAK/hERG1 complex formation is an early event that could depend on the cell 
lines and its integrins expression profile.  
 
Panc1 HEK-C5 
100kDa WB: β1 
IP: β1  
WB: FAK 
WB: hERG1 
  90’     45’     5’  120’   30’     5’ 150kDa 
150kDa
 
                         
b
 
 
              
c
 
                          
d
  
a 
  
Results and Discussion 
 
78 
0 30 60 90 120 150
0.0
0.2
0.4
0.6
0.8
1.0
1.2
hERG1/Beta1 complex formation
A
rb
ita
ry
 V
al
ue
s
Time (Minutes)
 PANC1
 HEK C5
b
0 30 60 90 120 150
0.0
0.2
0.4
0.6
0.8
A
rb
it
ar
y 
V
al
u
es
Time (Minutes)
 PANC1
 HEK C5
FAK/Beta1 complex formationc
 
Figure14. The time-course of co-IP between β1/FAK and β1/hERG1 channels in Panc1 and hERG1 
expressing HEK-C5 cells. (This observation is a representative of only one experiment).  
We further investigated the role of activation of FAK especially 
autophosphorylation of FAK (pFAK) at 397th amino acid residue tyrosine in Panc1 
cells. We observed that pFAK at the basal level when cells were seeded on non-
stimulating PLL. The pFAK was increased on FN and blocking of hERG1 channels 
decreased the pFAK. Insert hERG1 effect on pFAK.  
4.4.4. HERG1 channels are not involved in focal adhesions (FAs) and area 
of FAs of FAK and paxillin.  
We further pursued our interests in understanding the role of hERG1, if any, 
on focal adhesions and area of focal adhesions. Panc1 and BxPC3 cells were seeded 
on FN and treated with E4031 for the above mentioned time intervals. The cells were 
fixed, permeabilized and stained for cytoskeleton proteins FAK and paxillin. The 
number of focal adhesions of FAK and paxillin were quantified using the imageJ 
software according to Horzum et al., 2014. The cells showed increased number of 
FAs of both FAK and paxillin with time while the area of each of their FA decreased 
with time (figure 15).  
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Figure15: The effect of E4031 was further studied on its impact on focal adhesions of FAK 
and paxillin and the area of FAs. The number of FAs of FAK (a) and Paxillin (c and d) 
increased as cell adhesion matures, while the surface area of FAs of both FAK and paxillin 
decreased and formed more defined smaller FAs (b and e). The E4031 treatment did not 
show any impact on number of FAs and area of FAs.  
Panc1 cells showed significantly higher number of FAs of FAK and paxillin 
than BxPC3 cells but similar area of per FA. The E4031 treatment, however, did not 
influence both number of FAs and area of FAs (figure 15).  
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4.4.5. HERG1 channels are involved in altering actin cytoskeleton 
organization mediated by β1 integrins 
As mentioned above the integrins-ECM engagement activates the integrins by 
changing the conformation from bent to upright position. This in turn leads to the 
recruitment of several proteins at the cytoplasmic tail of the integrins to further 
activate the integrins and form focal adhesions (FA). Thus both ECM binding domain 
at the extracellular and intracellular protein binding cytoplasmic domain are crucial 
for cell adhesion, signaling and provide structure to the cells. The stable structure to 
the attached cells is provided by number of cytoskeletal proteins like actin, tubulin 
etc. So we sought to study the (i) organization of the actin organization regulated by 
cytoplasmic tail of β1 integrins and (ii) whether hERG1 channels also play a role cell 
adhesion and actin organization. To this purpose, mouse fibroblast GD25WT cells, 
that lack β1 integrin, were stably transfected with plasmid coding for β1 integrin 
truncated at cytoplasmic tail (β1Tr) and full-length β1A. These cells were seeded on 
FN to observe the differences in cell morphology and actin cytoskeleton organization. 
The f-actin staining by rhodamine conjugated phallodin showed that both GD25 WT 
and GD25 β1Tr had more dispersed shorter f-actin that were localized near the cell 
membrane and cells exhibited round shape morphology Whereas GD25 β1A cells, 
that has full-length cytoplasmic tail, showed more organized longer f-actin that were 
spread along the cells providing more stable cell structure and spread morphology 
(figure 16 top panel). We then seeded Panc1 and BxPC3 cells on FN and PLL and 
observed that cells seeded on FN showed spread morphology and longer f-actin than 
cells on PLL (Figure 16 bottom panel).  
 
GD25 β1A GD25 β1Tr GD25WT 
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Figure 16. Filament-actin staining was performed with rhodamine-conjugated phallodin in Panc1 and 
BxPC3 cells seeded on FN and PLL. The f-actin was highly localized in the cytoplasm when cells were 
seeded on FN and provided spread morphology to the cells as well as longer actin stress fibres. But on 
PLL, where the cell attachment is not mediated through engagement of integrins showed that f-actin is 
mostly localised near the membrane with much shorter length.  
After establishing the study that full-length β1 integrins as well as ECM are 
essential for cell spread morphology and cytoskeleton organization we investigated 
whether hERG1 channels are involved in modulating the cell adhesion and 
cytoskeleton organization. To study the role of hERG1-mediated changes in actin 
organization we used endogenous high and low hERG1 expressing Panc1 and BxPC3 
cells, transiently transfected hERG1 gene in HEK293 and mouse fibroblast 
GD25β1A cells. Panc1 and BxPC3 cells were seeded on fibronectin and treated with 
hERG1 blocker E4031 for 6, 24 and 48hrs, fixed with 4% PFA and stained for actin 
using rhodamine-conjugated phallodin as per the protocol. HERG1 activator NS1643 
(50μM) was also tested on Panc1 cells. On the other hand non-hERG1 expressing 
HEK293 and GD25β1A cells were transiently transfected with hERG1-GFP plasmid, 
seeded on fibronectin and stained for actin. The raw images of the cells stained for f-
actin were obtained from confocal microscopy and processed using MatLab codes to 
identify only the actin filaments (figure 17) (Balcioglu H.E et al., 2015).   
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Figure 17. All the above cells were stained for f-actin and images were captured using confocal 
microscope. The images were further processed by MatLab program to detect only f-actin filaments. 
The functional hERG1 expressing cells show more scattered and shorter filaments that hERG1 non-
expressing or herg1 blocked cells. 
The functional blocking of hERG1 channels by E4031 treatment for 24h 
induced longer and more organized f-actin stress fibres in Panc1 cells. On the other 
hand the hERG1 activator did not induce any changes compared to untreated cells 
(figure 17 a, b, c). We did not observe any changes in f-actin length and organization 
in BxPC3 cells (figure 17 d, e). This is consistent with the fact that BxPC3 cells 
express very low amount of hERG1 channels. The observation that f-actin 
organization was linked to hERG1 activity was further corroborated by experiments 
in which HEK293 and GD25β1A cells were transfected with functional hERG1 
channels (figure 17 f-i). In fact, non-hERG1 expressing HEK293 (figure 17g) and 
GD25β1A (figure 17i) showed actin organization similar to that of functional 
blocking of the channels in Panc1. On the contrary, the f-actin organization in hERG1 
positive HEK293 and GD25β1A was similar to that of Panc1 cells in control 
conditions. The alterations in the f-actin length were quantified using MatLab codes 
and expressed in μm. The average number of f-actin filaments varied between cells 
from 900 to 4000 filaments and the mean value of all the actin lengths, without 
setting the threshold, is represented below (figure 18). As can been observed from the 
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figure 18 the hERG1 gene transfection in GD25B1A and HEK293 cells decreased the 
actin filament length compared to un-transfected cells. On the contrary functional 
blocking of hERG1 in Panc1 cells increased the length of actin filaments. This 
observation is significant especially from cell migration point-of-view. Because for 
the cells to migrate, the lamellum, that has high density of actin filaments (100/μm), 
must be pushed forward. Long and flexible actin filaments cannot sustain the pushing 
force hence; cells create dense nascent filaments that are short-branched filaments to 
push against the membrane and provide structural basis for polymerization-driven 
protrusion (Pollard T.D and Borisy G.G, 2003). Therefore we argue that blocking of 
hERG1 channels impair the cell migration by inducing changes in actin organization.  
We further measured the cell-spread area and observed that E4031 treatment 
(in hERG1 expressing Panc1 cells) or non-hERG1 expressing cells showed more 
spread area and that untreated or hERG1 transfected cells (figure19). This 
observation was particularly evident in hERG1 transfected GD25β1A fibroblast cells 
that was significantly large cells. The control HEK293 cells, on the other hand, are 
much smaller in size and hence hERG1 transfection in these cells decreased the cell-
spread area to lesser extent. However, surprisingly the hERG1 blocking in Panc1 
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Figure 18. The histogram above is the average length of the actin filaments. The cells that are 
expressing functional hERG1 channels have shorter filaments compared to the cells that are either 
non-hERG1 expressing or hERG1 expressing cells that are treated with hERG1 channel blocker. The 
statistical significance was tested by Brown-Forsythe test and <5% is considered as statistically 
significant (p≤0.01). 
cells did not change the surface area of the cells. This could be because of the fact 
that endogenous expression of hERG1 channels in Panc1 cells was much lower than 
in the cells transfected with hERG1 channels. At this point of time we could only 
speculate that the level of hERG1 expression in Panc1 cells was adequate to alter the 
actin organization but not adequate to cause hyper polarization that could have any 
impact on cell area (or volume) and hence further characterization of hERG1 in 
Panc1 cells is required. However, neither hERG1 blocking nor hERG1 expression 
altered the orientation of actin filaments (figure20). Thus we conclude here that 
hERG1 channels are involved actin filaments organization and cell-spread area but 
not on actin orientation that are mediated through interactions with β1 integrins.  
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Figure19. The role of hERG1 expression in cell surface area was studied. The over expression of 
hERG1 channels in GD25 β1A and HEK293 cells decreased the cell surface area compared to WT 
cells.  
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Figure20. The over expression of hERG1 channels or functional blocking of hERG1 channels (in 
Panc1) did not alter the actin orientation (angle).  
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4.5. HERG1 channels in PDAC cell migration stimulated by 
activated PSC through actin dynamics and altered 
calcium concentration 
4.5.1. Functional blocking of hERG1 channels mitigate the PDAC cell 
migration through altered actin dynamics and decreased 
intracellular calcium concentration  Finally, we aimed to study the role of hERG1 channels in actin dynamics. 
This work was performed in the laboratory of Professor Albrecht Schwab, University 
of Munster, DE. Here we challenged the hERG1 role in more complex and dynamic 
experimental setup that is closer to physiological conditions of PDAC. The PDAC is 
characterized to be highly desmoplastic with excess deposition of collagen matrix 
around the tumor cells. The PDAC tumor microenvironment is also highly complex 
and dynamic. It includes pancreatic stellate cells (PSCs), immune cells, lymphocytes, 
endothelial cells and the secretomes of this individual cell types. The secretomes of 
one set of cells can stimulate other cells and vice-versa and trigger tumor progression. 
As tumor cells grow, the blood supply is hindered. This mainly occurs in central 
portion within the tumor mass that is hence deprived of oxygen called as hypoxia. It 
is worth noting that oxygen is essential to support tumor growth. This hypoxic 
condition in PDAC adds new dimension to the already complex disease. Due to the 
limitation of oxygen the tumor and stromal cells evolve to sustain the growth as 
tumor progresses. In addition, the hypoxic condition triggers the signaling pathways 
that directly induce the pro-invasive programming in cancer and stromal cells (Yuen 
A and Diaz B, 2014). Further, both in vitro and in vivo studies show that hypoxia 
activates PSCs and in turn increases fibrosis and angiogenesis (Masamune A et al., 
2008). PSCs activation leads to increased secretion of various growth factors, ECMs, 
cytokines, interleukins etc. that increase the interaction with nearby PDAC cells 
(Eguchi D et al., 2013). There are more than 650 proteins that are secreted by 
activated PSCs, compared to ~45 proteins from quiescent PSCs, and >27% of these 
proteins are implicated in cellular processes, metabolism and human diseases (Wehr 
A.Y et al., 2011). Hence activated PSCs have been increasingly proven to play key 
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role in promoting as well as protecting the PDAC against the tumor targeting 
(McCarroll J.A et al., 2014) and perceived to be a potential target to control the tumor 
progression. We aimed to study the interactions between PDAC and stellate cells and 
whether hERG1 channels are involved in the interactions. Thus we first characterized 
the expression level of β1 integrins and hERG1 channels in PSCs cells. 
Immunofluorescence experiments show that PSCs have high expression of β1 
integrins and no hERG1 expression (figure 21a and b). The patch clamp experiments 
were performed to study the presence of hERG1 current and observed that E4031 
treatment decreased the hERG1 type current by meagre -10pA thus considered as 
insignificant (figure 21c). 
 
Figure 21: Immunofluorescence staining in PSC cells shows high surface expression for β1 (a) and 
very low signal for hERG1 (b). Whole-cell patch clamp experiments confirm small traces of hERG1 
current that was abolished when cells were treated with E4031 (c).  
Then, we attempted to study the co-culture migration between PDAC and 
PSC cells on more closely to physiological matrix composition. We labelled the 
PDAC cell Panc1 with rhodamine-conjugated nanoparticles to differentiate from 
PSCs. Due to the lack of significant number of labelled cells within the microscopic 
field per experiments and unhealthy labelled cells we could not quantify co-culture 
migration and role of hERG1 channels in co-culture migration (data not shown). So 
a 
b 
c 
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we switched to single cell migration of Panc1 cells stimulated by activated PSCs and 
the data are reported below.  
4.5.2. HERG1 channel blocker E4031 decreases the Panc1 cells migration 
stimulated by hypoxia  activated PSCs on desmoplastic matrix.  
Here we studied whether blocking the hERG1 channels would impair, at least 
in partial, the PDAC cell migration on two-dimensional matrix. In order to mimic the 
physiological tissue composition that exist within the desmoplastic microenvironment 
the T-flasks (12cm2) were coated with ‘desmoplastic matrix (DM)’ containing ~89% 
of collagen-1, 4.5% each of fibronectin and laminin, 1% each of collagen-III and 
collagen-IV. The matrix were gently mixed in RPMI medium containing HEPES 
buffer (see materials and methods section for details) and coated overnight at 37C for 
the matrix to polymerize. The immortalized hPSCs were grown to ~ 90% confluent 
and growth medium was changed to serum free DMEM medium (10ml). The hPSCs 
were then incubated in hypoxia incubator (1% CO2) for activation for not more than 
18h and conditioned medium (filtered using 0.22μm filter) was used for the 
stimulation of Panc1 cells. Approximately 70,000 Panc1 cells were seeded on DM 
and allowed to attach and spread (~2h). The Panc1 cells were stimulated with 
conditioned medium, without dilution, of hPSCs (2.5ml). Immediately cells treated 
with hERG1 blocker E4031 and during the course of the experiments. In addition, 
two sets of medium were used as stimulant; (i) conditioned medium of hPSCs cells 
incubated in normoxia incubator and (ii) only serum free DMEM medium incubated 
in hypoxia incubator for 18hrs. The cell migration video was generated using time-
lapse images with interval of 5mins for 6hrs. For the analysis of migration every 
second image (that is 10mins interval) between 2-6hrs was considered. The track of 
random cell migration show that both the conditioned medium from normoxia and 
hypoxia hPSCs increased the Panc1 cell migration significantly compared to un-
conditioned medium (figure 22 top panel). The increase in normoxia-conditioned 
media stimulated Panc1 cell migration could be reasoned that hPSCs are 
immortalized and activated cells that have characteristic features of lost Vitamin A 
droplet and expression of α-smooth muscle actin (α-sma) (Jesnowski R et al., 2005). 
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As mentioned above the activated hPSCs stimulate various soluble factors like GFs, 
ILKs etc. that stimulate the cells. Hence we reason that these immortalized and 
activated PSCs, though maintained in normoxia conditions, could stimulate cell 
migration. The E4031 treatment significantly decreased the cell migration in both 
non-stimulated and stimulated conditions (figure 22 bottom panel). 
 
Figure 22. The position or location of each cell was normalized to origin. The direction of random cell 
migration was tracked using Amira software and represented on X and Y-axis.  
We further quantified the translocation of the cells from starting point, the 
total distance, the speed at which the cells migrated, the directionality of the 
migration, structure index (SI) and surface area of the cells during the course of the 
experiments were quantified using the ImageJ software. The cell migration rate, 
translocation of the cells from the original point to end and total path of the cell 
migration are shown in figure 23. The non-stimulated cells migrated shorter distance 
and at slower speed than cells stimulated with conditioned medium from both 
normoxia and hypoxia activated hPSCs. Interestingly, the hERG1 blocker E4031 
showed highest inhibition of cell migration rate and total path, by ~45% each, under 
Non-conditioned media-control Normoxia condn media-control 
 
Hypoxia condn media-control 
Non-conditioned media + E4031 Normoxia condn media + E4031 Hypoxia condn media + E4031 
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hypoxia conditioned media compared to both normoxia (25%) and non-conditioned 
(35%) medium.  
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Figure 23. The quantification of Panc1 cell migration stimulated media conditioned media of activated 
hPSCs. Panc1 cells stimulated under normoxia and hypoxia conditioned medium showed higher cell 
migration rate (a), translocation of the cells from the origin point (b) and longer total path migrated 
than the cell stimulated with non-conditioned medium. The hERG1 blocker E4031 (40μM) decreased 
the migration of cells under all stimulation conditions.  
As can be observed from the cell track in figure 22 the directionality of the 
cells were random and blocking the channel restricted the migration without altering 
the directionality. However, E4031 altered the morphology of the cells (represented 
as structure index, SI) in non-conditioned and hypoxia stimulation conditions and not 
in significantly enough in normoxia conditions (figure 24a) whereas E4031 showed 
inconsistent effect on the total surface area of cell in these conditions (figure 24b). 
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The SI close to 1 represents that cells are near round shaped while SI close to 0 
represents more polarized or flattened structure.  
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Figure 24. The changes in the structure index (S.I) (a) and surface area (b) of the migrating cells were 
calculated and represented here is the average during the four-hour migration. The S.I of cells were 
increased in E4031 treatment, but to a lesser extent in normoxic condition (n.s->non-significant 
statistically). The effect of E4031 on surface area was however inconsistent in each conditions.  
The cell migration rate (and hence total path) was consistent during the course 
of the experiment. The cells treated with E4031 showed the inhibition effect on the 
migration that persisted throughout the experiment (figure 25).  
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Figure 25. The time course of cell migration rate under the stimulation of in non-conditioned, 
normoxic and hypoxic conditioned media. The cell migration rate was constant throughout the 
migration (4hrs) and inhibitory effect of E4031 was immediate and persistent during the migration 
period.  
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4.5.3. HERG1 channel blocker E4031 alters the actin dynamics of the 
migrating Panc1 cells stimulated by conditioned medium of 
hypoxically activated PSCs. 
The actin dynamics was studied by transfecting the Panc1 cells with plasmid 
harbouring lifeAct-GFP gene. The analysis of actin dynamics was performed in 
collaboration with Dr Stefano Coppola, University of Leiden, NL. The lifeAct-GFP 
stains for f-actin filaments without interfering with its dynamics (Riedl J et al., 2008). 
The lifeAct-GFP transfected Panc1 cells were seeded on thin coating of DM (1/10th 
of used in migration) with the same composition of migration set-up. When the cells 
were attached and spread they were stimulated with PSC conditioned media and 
immediately treated with E4031. The GFP stained actin filaments were visualised 
under TIRF microscope and images were acquired for two minutes with 1second 
interval. To assess the actin dynamics, the time series of images were analysed using 
the spatio-temporal image correlation spectroscopy (STICS) method (Hebert B et al., 
2005). Below is the representative image of Panc1 cells that was analysed for the 
actin dynamics of flow map generated by STICS analysis (figure 26). Each arrow 
represents the velocity vector of the actin filaments.  
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Figure 26. Representative image of the actin flow map in Panc1 cells used to study the actin 
dynamics/velocity stimulated by either PSCs conditioned medium. The red arrow represents the 
velocity vector within the corresponding region of interest (ROI). The scale bar is 10 μm and the red 
arrow below the scale bar represents the reference velocity of 0.05 μm/s.   
Figure 27 shows the boxplot for the velocity of actin flow obtained from the 
STICS analysis. There is significant difference for the E4031 treatment with respect 
to the control. The PSC stimulation increases the actin dynamics by changing the 
flow magnitude. The actin filaments have two ends; barbed and pointed ends that are 
dynamically different with barbed end is 10 times more dynamic and fast growing 
end of the actin filaments (Blanchoin L et al., 2014). The formation of f-actin 
filaments (polymerization) is initiated by spontaneous nucleation of monomeric unit 
of actin (globular-actin or G-actin). Hence the growth of the f-actin depends on the 
concentration of the readily available G-actin for assembling called as critical 
concentration (Cc). When the f-actin is formed under steady state condition there is 
equilibrium between association and dissociation of G-actin from the filament actin. 
In the so-called treadmilling of actin filaments there is constant association and 
dissociation of G-actin. From the treadmilling point of view our analysis is no more 
than a flow (the association/disassociation of G monomers lengthens or shortens the 
actin filaments substantially mimicking a motion in a specific direction, i.e. a flow). 
The velocity of actin flow was estimated to be 0.008± 0.003 μm/s and 0.0089±0.0057 
for 1h and 24h stimulation control conditions respectively. The E4031 treatment 
however, significantly (statistically) increased the velocity of actin flow to 
0.0102±0.0103 and 0.0102±0.0113 for 1h and 24h treatment respectively. The 
diffusion co-efficient of actin was also increased in E4031 treatment compared to 
control conditions (figure 27 left panel).  
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Figure 27. The velocity of actin dynamics or flow was analysed using STICS method. The 
conditioned medium of PSCs increases the actin dynamics by increasing the flow magnitude.  
4.5.4. HERG1 channel blocker decreases the intracellular concentration 
of calcium and in Panc1 cells stimulated by PSC conditioned media.  
In the previous sections, hERG1 channels are shown to be involved in Panc1 
cell migration and actin dynamics. Panc1 cells were stimulated by PSC secretomes on 
DM and hERG1 blocker inhibited the cell migration and actin dynamics drastically. 
We further set to study the possible mechanism that is involved in the hERG1 
mediated cell migration and cytoskeleton organization including actin dynamics. 
Calcium is one of the most essential chemical elements required for the human 
beings. While at the organismic level, Ca2+ with other compounds composes the 
bone to support the bodies, at the tissue level Ca2+ compartments regulate membrane 
potential in neuronal and cardiac activities and at the cellular level Ca2+ 
concentrations determine the cellular physiology including cell proliferation, death 
and migration (Tsai F.C et al., 2015). The intracellular Ca2+ concentrations are 
spatially and temporally regulated with precision. Within the migrating cells the 
Ca2+ concentration is gradient with higher concentrations at the cell rear and very 
low concentration at the cell front  (Wei C et al., 2012). This global gradient of the 
Ca2+ concentration inside the cell could partly due to distribution of subcellular 
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Ca2+ storing organelles. Most of the migration machineries like actin, focal adhesion 
complexes and the regulatory components like small GTPases are all Ca2+ sensitive, 
hence the fluctuations in Ca2+ concentration, expectedly, will have an effect on cell 
migration. Most of the intracellular Ca2+ concentration is derived from the 
endoplasmic reticulum, however the changes in membrane potential can also drive 
Ca2+ influx for ex through transient receptor potential (TRP) channels or through 
store-operated Ca2+ entry (SOCE). The actin dynamics has shown to be regulated 
due to changes in Ca2+ influx. For ex, depolarization of neuron cells led to influx of 
Ca2+ that altered actin bundle and retrograde flow (Welnhofer E.A et al., 1999). 
Although Ca2+ does not bind directly to actin bundles it affects the multiple actin 
regulators. Small Rho GTPases like Rac1, RhoA and Cdc42 are key regulators of 
actin dynamics in a spatially dependent manner; Rac1 is localized in lamellipodia, 
RhoA around FAs and Cdc42 in filopodia. These GTPases also regulate each other in 
cyclic manner and synchronised for the efficient cell migration (Tsai F.C et al., 
2015). To this end we aimed to study the role of hERG1 channels in intracellular 
Ca2+ concentration as well as the activities of Rho GTPases that regulate actin 
dynamics. Panc1 cells were seeded on the DM matrix as mentioned in actin dynamics 
experimental setup (10% of total matrix composition in cell migration) and cells were 
stimulated for 1hr with conditioned media of hypoxically activated PSCs. The 
calcium measurement was performed as detailed in materials and methods section. 
Scheme 9 below shows the measurement events in the intracellular calcium 
measurement setup.  
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Scheme 9. A typical experimental scheme of intracellular calcium measurement in perfusion 
system that includes drug treatment and calibration buffers (0mM and 5mM). 
 
The Panc1 cells that are seeded on DM and stimulated with PSC conditioned 
medium for 1hr showed the average [Ca2+]i to be around 190nM. In the same setp 
when cells were treated with E4031 we observed the decrease in the final [Ca2+]i by 
more than two-fold to 85nM. Interestingly when Panc1 cells were seeded on FN 
without stimulation the [Ca2+]i was ~140nM which was decreased to ~65nM with 
E4031 treatment. To confirm these observations of the role of hERG1 channels on 
[Ca2+]i we used hERG1 transfected HEK293-C5 and mock plasmid transfected 
HEK293-Mock cells. The Ca2+ concentration in HEK-C5 cells was around 170nM 
that was decreased to ~80nM while HEK-Mock cells showed the [Ca2+]i around 
90nM and E4031 treatment showed less significant decrease in concentration to 
~63nM (figure 28). Hence we conclude that hERG1 channels regulate cell migration 
and actin cytoskeleton organization through interactions with β1 integrins and this 
regulation could be due to the decreased [Ca2+]i. We speculate that there could 
perhaps be indirect interactions between hERG1 and calcium permitting channels like 
transient receptor potential (TRP) channels and therefore further investigation is 
necessary.  
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 Figure 28. The intracellular Ca2+ concentration was measured using calibration buffer consisting 
of 0mM and 5mM Ca2+. The time course of intracellular concentrations was measured at the end of 
treatment. The concentration was estimated for at least 10 time points over-a-period of 100 seconds. The 
hERG1 blocker E4031 decreased the intracellular concentration by more than 2 fold in both PSC stimulated 
Panc1 cells seeded on DM matrix (a) and non-stimulation on FN (b). The exogenous expression of hERG1 
channels in HEK293 cells also showed drastic increase in intracellular Ca2+ compared to mock transfected 
HEK293 cells. The E4031 treatment decreased the elevated Ca2+ concentration to that of HEK-mock cells 
and E4031 has little effect on HEK-mock (c). The overall intracellular concentration of Ca2+ is at least 2 
fold lower when cells expressing hERG1 were treated with E4031 (d).    
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5. CONCLUSION REMARKS 
 
Cancer cell arises from the transformation of normal cell that has characteristic 
features of slow and limited proliferative capabilities. During the transformation 
normal cells acquire series of genetic mutations that eventually lead to becoming 
cancer cells that has ever-proliferating capabilities and at much faster rate. At the 
molecular level the cancer cell possesses the alterations in vast number genes that are 
otherwise tumor suppressor genes. More often the tumor suppressor genes are either 
mutated or deleted for ex. TP53, or tumor-enhancing gene (oncogenes) are 
constitutively activated for ex. KRas that ever induce cell proliferation. In addition 
there are many membrane proteins that are also highly expressed. This includes, 
among many other membrane proteins, epidermal growth factor receptors (EGFR), 
several integrin receptors, ion channels etc.  
 
The roles of ion channels in regulating the cellular functions including cell cycle 
progression, cell-volume regulation and other physiological processes have been well 
studied. In addition there has been increasing evidence that ion channels are also 
implicated in all most all cancer besides other pathological conditions. The groups of 
pathological conditions in which ion channels are implicated are termed as 
channelopathies. In primary cancer or cancer cell lines ion channels’ expression is 
generally up regulated although some ion channels are also down regulated. 
Potassium ion channels are the single largest class of ion channels that are expressed 
in cells. The voltage-gated potassium ion channels HERG1 also called as hERG1 is 
expressed by gene KCNH2. The hERG1 channels are aberrantly expressed in most of 
the cancers including pancreatic ductal adenocarcinoma (PDAC) and hence serve as a 
marker for diagnosis and potential targets for therapy. 
 
Firstly, we studied the role of hERG1 channels in PDAC cell lines (Panc1, 
MiaPaCa2 and BxPC3). Our study shows that hERG1 channels are differently 
expressed in these cell lines and primary tumours in human. The functional blocking 
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of the channels by hERG1 specific small molecule drug E4031 showed inhibitory 
effect on cell proliferation and anchorage independent cell survival of PDAC cells. 
Further study demonstrates that the inhibitory effect on cell proliferation was 
mediated through MAPK/ERK signaling pathway in Panc1 cells (Lastraioli et al., 
2015).  
 
Secondly, we reasoned that hERG1 channels could be, in partial, regulating 
the cell proliferation through interactions with EGFRs and integrins. So we 
immediately characterized the expression levels of EGFRs and surface expression of 
integrins β1 and αVβ5 on various ECM proteins. The EGFR expression was very 
high in all cell lines. Interestingly, the surface expression of both β1 and αVβ5 was 
greatly enhanced when Panc1 cells were seeded on FN. The interactions between 
hERG1, EGFR and β1 and αVβ5 were studied through co-immunoprecipitation (co-
IP) experiments. The experiments revealed that hERG1 makes macromolecular 
complex formation between EGFR, β1 and αVβ5 integrins. Interestingly, hERG1 
strongly co-localizes with only β1 integrins. However, complex formation (both co-
IP and co-localization) between hERG1 and β1 was conditional; that is hERG/β1 
complex formation occurred only when β1 integrin was activated by ECMs and 
hERG1 channel was functional. Hence we pursued our interests in understanding the 
mechanism involved in interactions between hERG1 and β1 integrins. When Panc1 
cells were seeded on PLL or when cells were treated with E4031 the hERG1/β1 
complex formation was drastically reduced.  
 
Thirdly, we attempted to study which domains in hERG1 and β1 could be 
involved in complex formation. For this purpose we used non-hERG1 expressing 
HEK293 cells transfected with variants of hERG1 channels that do not harbour N or 
C-terminus domain. On the other hand we also used mouse fibroblast GD25WT cells 
that is negative for β1 integrins. GD25WT cells were co-transfected with (i) β1 
integrin coding gene devoid of cytoplasmic tail and full-length hERG1 and (ii) full 
length β1 and hERG1. Our co-IP findings suggest that cytoplasmic domains of both 
hERG1 and β1 are not necessary for the interactions. Further characterization shows 
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that the closed state conformation of the hERG1 channel is more favourable for 
complex formation with β1 integrins.  
 
Fourthly, based on the above observations we hypothesized that hERG1 
channels could modulate the integrin mediated functions like cell adhesion, 
migration and cytoskeleton organization. The time course of cell adhesion on FN was 
unaltered when Panc1 cells were treated with E4031 or hERG1 channels were 
transfected in HEK293 cells. This was also supported by the fact the number and area 
of focal adhesions of FAK and paxillin (two of the most important focal adhesion 
proteins that are recruited at the early stage of cell adhesion) was also unaffected with 
E4031 treatment. However, E4031 treatment reduced the migration of Panc1 cells 
(Lastraioli et al., 2015). This prompted us to hypothesize that hERG1 could be 
involved in modulating the migration machineries of cells most notably cytoskeleton 
proteins like actin. In deed Panc1 cells treated with E4031 altered the actin 
cytoskeleton organization in Panc1 cells. The functional blocking of hERG1 by 
E4031 treatment produced more organized and longer actin filaments that are spread 
along the cell body than control conditions where the actin filaments are significantly 
shorter and dispersed. This observation was further strengthened when HEK293 and 
GD25WTβ1A were transfected with functional hERG1 channels. The over 
expression of hERG1 channels produced shorter and dispersed actin filaments similar 
to control Panc1 cells. In addition, due to the alterations in actin organization we 
observed the decrease in cell spread area especially in hERG1 over expressing 
HEK293 and GD25WT β1A cells. However, the orientation of actin filaments was 
constant. The overall functional role of hERG1 channels in Panc1 cells in interactions 
with EGFR and integrins has been summarized in the schematic representation above 
(scheme 9).   
 
Finally, we challenged the role of hERG1 channels in regulating cell 
migration and actin cytoskeleton in more complex and multifactorial system. To this 
purpose we studied the role of hERG1 channels in Panc1 cells migration stimulated 
by hypoxically activated PSCs’ conditioned medium. The Panc1 cells were plated on 
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desmoplastic matrix (DM) coating and cells were stimulated with conditioned 
medium of PSCs. 
 
 
Scheme 9: The above scheme represents the interactions of functionally active hERG1 channels with 
EGFR and β1 integrins in tumor microenvironment mimicked in vitro. Functionally active hERG1 
channels interact with EGFR and integrins and, modulate the intracellular signaling pathways that 
are implicated in cell proliferation, anchorage independent survival and cell migration. Functionally 
active hERG1 channels interact with EGFRs and increase pro-proliferative cell signaling through 
RAS/ERK pathway (increased phosphorylation of ERK1/2). HERG1 channels interact with β1 
integrins in more tightly and co-ordinated manner. In fact hERG1 and β1 integrins are shown to be 
co-localized and regulate integrin mediated cell migration, signaling pathways as well as actin 
cytoskeleton organization. The functional hERG1 channels lead to increased cell migration and 
shorter and dispersed actin filaments. This could be due to the increase in [Ca2+]i, perhaps through 
TRPM8 cells and therefore further investigation is necessary.  
 
The PSCs’ conditioned media significantly increased the cell migration compared to 
non-conditioned medium. HERG1 blocking showed highest inhibition of cell 
migration stimulated by conditioned media. Further we attempted to study the 
changes in the dynamics of actin organization in the same set up. Spatio-temporal 
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image correlation spectroscopy (STICS) method reveals that E4031 treatment 
significantly increased the actin dynamics as well as diffusion co-efficient of actin in 
contrast to control conditions. We reasoned that the changes in actin organization and 
dynamics due to blocking of hERG1 channels could be because of the shift in the 
calcium concentrations. Because hyperpolarization of breast cancer cells by 
activating the hERG1 channels has shown to increase the calcium influx, which was 
however completely reversed by generic calcium channel blocker CoCl2 (Neut M.P 
et al., 2015). In addition, the cytoskeleton proteins are calcium sensitive proteins and 
therefore it was noteworthy to study role of hERG1 channel blocking in intracellular 
calcium concentrations. Hence we measured the intracellular calcium concentrations 
between control and E4031 treatment events and observed that [Ca2+]i was decreased 
by more than two-fold when cells were E4031 treated. However, the exact 
mechanism through which the calcium entry was inhibited, due to hERG1 blocking, 
is not understood. We speculate that the calcium entry could be mediated through 
transient receptor potential cation channel, subfamily 8 (TRPM8), among many other 
calcium-permitting channels. The expression of TRPM8 channels is up regulated in 
Panc1 cells and hence further investigation for the establish the relation between 
hERG1 and TRPM8 channels is essential for better understanding of the underlying 
mechanism. The overall effect of functional blocking of hERG1 channels by E4031 
on interactions with EGFR and integrins has been summarized in the schematic 
representation below (scheme 10).   
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Scheme10. The above scheme represents the interactions of functionally blocked (by E4031) hERG1 
channels with EGFR and β1 integrins in tumor microenvironment mimicked in vitro. When hERG1 
channels are functionally blocked we observed the decreased in phosphorylation of ERK1/2 (shown as 
single P) that lead to slower growth rate of cells. The E4031 showed the highest effect in the 
interactions between hERG1 and β1 integrins. In fact, E4031 treatment impaired the co-localization 
between hERG1 and β1. Further, E4031 treatment decreased the cell migration and produced longer 
and more organized actin filaments. The E4031 also decreased the [Ca2+]i..
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